All conditions

Chronic Kidney Disease

Plain English clinical trial information, updated daily from ClinicalTrials.gov and public government registries. Not medical advice.

3488
Trials on record
361
Recruiting now
11
Australian sites
37
Phase 3 trials
2
PBS medicines
How these figures are counted
  • Trials on record is every trial tagged to this condition at any stage, except those withdrawn before starting or terminated early. Most are completed rather than ongoing, so this is a measure of research history, not of current activity. It is also smaller than the sitewide "trials tracked" figure, which does include withdrawn and terminated trials.
  • Recruiting now counts only trials whose registry status is "Recruiting". Trials listed as not yet recruiting or enrolling by invitation are excluded, so this understates how many may open to new participants soon.
  • Australian sites counts trials counted under "Recruiting now" that list at least one Australian site. A site being listed does not mean it is currently enrolling, and Australian trials registered only on ANZCTR are not counted yet, so this understates local availability.
  • Phase 3 trials counts trials counted under "Recruiting now" that are at Phase 3.

Find recruiting trials for Chronic Kidney Disease →

Get alerts when Chronic Kidney Disease trials change ↗

Voxsanity currently covers 103 conditions. We are expanding coverage regularly.

Understanding Chronic Kidney Disease

Chronic Kidney Disease, often called CKD, is a condition where the kidneys gradually lose their ability to filter waste products and excess fluid from the blood. Healthy kidneys work around the clock to clean your blood, balance minerals, and produce hormones your body needs. When CKD develops, this filtering ability slowly declines over months or years. The condition is described in stages, from mild (Stage 1) through to severe (Stage 5), based on how well the kidneys are still working. Importantly, many people with early-stage CKD feel no obvious symptoms at all, which is why it is often discovered through routine blood or urine tests.

CKD is surprisingly common in Australia. Around 1 in 10 Australian adults has some signs of the condition, and it becomes more common with age. Diabetes and high blood pressure are the two leading causes, though CKD can also result from inherited conditions, repeated kidney infections, or certain medications. Aboriginal and Torres Strait Islander people are disproportionately affected, experiencing CKD at higher rates and often at younger ages than the broader population.

Treatment for CKD generally focuses on slowing the progression of the disease and managing related health issues. This typically involves regular monitoring through blood and urine tests, managing blood pressure, controlling blood sugar levels in people with diabetes, and making certain changes to diet and lifestyle. For people whose kidney function declines to a very advanced stage, options such as dialysis or a kidney transplant may become relevant. A team of health professionals, which may include a kidney specialist called a nephrologist, a dietitian, and a GP, usually works together to support people living with CKD.

This overview is an AI generated summary written from public medical sources and checked on a sample basis. It is general information, not medical advice or a diagnosis. Always speak with your doctor about your situation. How we use AI

Can you access treatment for Chronic Kidney Disease in Australia right now? Here's what's publicly known.

Information on this site does not constitute medical advice. Data is sourced from publicly available government registries. Always consult your doctor before making any health decisions. Trial status should be verified directly with the trial site.

Updated regularly from public government registries

PBS-subsidised medicines for Chronic Kidney Disease

2 medicines listed on the PBS for Chronic Kidney Disease. Filter by authority type, or open the full table below.

What the authority types mean Unrestricted: no clinical criteria; a doctor can prescribe it on the PBS for any appropriate use. Restricted benefit: subsidised only for the specific conditions or uses set out by the PBS. Streamlined authority: restricted, but the doctor does not need prior approval; they record a streamlined authority code confirming you meet the criteria. Authority required: restricted, and the doctor must get prior approval from Services Australia (by phone or online) before it is subsidised. Source: Pharmaceutical Benefits Scheme (pbs.gov.au).
Full PBS medicines table 2 listed

These medicines are listed on the Pharmaceutical Benefits Scheme (PBS) for the specific indications shown. A listing does not mean a medicine is right for you; your doctor decides what is appropriate. Prices shown are the PBS-determined dispensed price. Most patients pay only the standard co-payment, up to AU$25.00 per script (general) or AU$7.70 (concession or Safety Net) in 2026, with the Australian Government subsidising the rest.

Medicine Brand(s) Listed for
enoxaparin sodium Exarane Forte, Clexane Safety-Lock Haemodialysis AU$23.34 Restricted benefit
difelikefalin Korsuva pruritus (itching) associated with chronic kidney disease Moderate to severe AU$540 Authority required

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.

Research pipeline

Where trials for Chronic Kidney Disease currently sit in the development pipeline. The funnel shape shows how few drugs reach later phases in general; the counts are this condition's actual trial numbers.

Phase success rates are industry-wide historical averages, not predictions for specific trials. Learn how trials work →

Most active research sponsors

Organisations with the most recruiting trials for Chronic Kidney Disease.

View sponsor profile
View sponsor profile
View sponsor profile
View sponsor profile
View sponsor profile

Where trials are running

Clinical trial sites for Chronic Kidney Disease by country. Australia is highlighted.

Showing the top 10 of 68 countries with trial sites.

Clinical trials for Chronic Kidney Disease

Showing 366 of 366 trials

The plain English eligibility text on each trial below is an AI generated summary of the official criteria, checked on a sample basis. How we use AI

🇦🇺 NCT00416520 · Tanabe Pharma Corporation Phase 3 · 11 countries Completed
Completed Phase 3 Est. completion 1 November 2009
🇦🇺 AU🇦🇹 AT🇨🇿 CZ🇫🇷 FR🇩🇪 DE🇭🇺 HU🇮🇹 IT🇵🇱 PL +3 more

Who might be able to join this trial: - You are a man or woman aged 18 or older - You are on haemodialysis or peritoneal dialysis (kidney filtering treatments) and your condition is stable - Your phosphate levels are being managed and are stable - You are following a set diet to control your phosphorus intake - If you...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT02876835 · GlaxoSmithKline Phase 3 · 39 countries Completed
Completed Phase 3 Est. completion 19 April 2021
🇦🇷 AR🇦🇺 AU🇧🇪 BE🇧🇷 BR🇧🇬 BG🇨🇦 CA🇨🇴 CO🇨🇿 CZ +31 more

**Who might be able to join this trial:** - You are between 18 and 99 years old - You have been diagnosed with moderate to severe chronic kidney disease (CKD stage 3, 4, or 5, as measured by a specific kidney function test) - If you are **not** currently using ESAs (red blood cell-boosting injections), you have not us...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT03029208 · GlaxoSmithKline Phase 3 · 15 countries Completed
Completed Phase 3 Est. completion 24 September 2020
🇦🇷 AR🇦🇺 AU🇨🇦 CA🇩🇪 DE🇮🇳 IN🇮🇹 IT🇲🇾 MY🇲🇽 MX +7 more

**Who might be able to join this trial:** - You are between 18 and 99 years old. - You are planning to start regular dialysis within the next 6 weeks, OR you have already been on dialysis for no more than 90 days and are not expected to stop during the study — this includes hemodialysis at least twice a week, or perit...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT05374291 · University Medical Center Groningen Phase 3 · 6 countries By Invitation
By Invitation Phase 3 Est. completion 1 July 2027
🇦🇺 AU🇧🇪 BE🇩🇪 DE🇳🇱 NL🇸🇬 SG🇪🇸 ES

**Who might be able to join this trial:** - You have advanced kidney disease with a kidney function level (eGFR) of 25 or below - You are on dialysis and have been receiving it for at least 3 months - You have had a kidney transplant at least 6 months ago and your kidney function level (eGFR) is 45 or below - You are...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT03573089 · The University of Queensland Not Applicable · 8 countries Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇦🇺 AU🇧🇷 BR🇨🇦 CA🇫🇷 FR🇮🇱 IL🇳🇿 NZ🇹🇭 TH🇬🇧 GB

Who might be able to join this trial: - You are 45 years old or older, OR you are 18 years old or older and have diabetes - Your kidneys have permanently stopped working and you are receiving dialysis (either haemodialysis or peritoneal dialysis) and have been on dialysis for at least 3 months - You are currently takin...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
🇦🇺 NCT05027906 · Eledon Pharmaceuticals Phase 2 · 5 countries Recruiting
Recruiting Phase 2 Est. completion 1 January 2027
🇦🇺 AU🇧🇷 BR🇨🇦 CA🇬🇧 GB🇺🇸 US

**Who might be able to join this trial:** - People who are 18 years of age or older - People who are receiving their very first kidney transplant, whether the kidney comes from a living or deceased donor - People who agree to use contraception during the study and for at least 90 days after the last dose of the study d...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT05099770 · Prokidney Phase 3 · 7 countries Recruiting
Recruiting Phase 3 Est. completion 1 December 2029
🇦🇺 AU🇨🇦 CA🇲🇽 MX Puerto Rico🇹🇼 TW🇬🇧 GB🇺🇸 US

**Who might be able to join this trial:** - People who are male or female, between 30 and 80 years of age at the time of signing consent - People who have been diagnosed with both type 2 diabetes and chronic kidney disease - People whose HbA1c blood sugar level measure is 9.5% or lower at the screening visit - People...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT05196035 · Bayer Phase 3 · 32 countries Recruiting
Recruiting Phase 3 Est. completion 31 May 2027
🇦🇷 AR🇦🇺 AU🇦🇹 AT🇧🇪 BE🇧🇷 BR🇧🇬 BG🇨🇦 CA🇨🇿 CZ +24 more

**Who might be able to join this trial:** - Children aged 6 months to under 18 years old at the time of signing the consent form. - Children who have been diagnosed with chronic kidney disease (CKD), a condition where the kidneys do not work as well as they should, meeting specific kidney function levels based on age...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT05457283 · Bayer Phase 3 · 32 countries Recruiting
Recruiting Phase 3 Est. completion 28 November 2028
🇦🇷 AR🇦🇺 AU🇦🇹 AT🇧🇪 BE🇧🇷 BR🇧🇬 BG🇨🇦 CA🇨🇿 CZ +24 more

**Who might be able to join this trial:** - You must be between 1 and 18 years old at the time of signing the consent form - You must have previously taken part in the FIONA clinical trial (study 19920) and must not have stopped the treatment early before the end of that trial - You must have a confirmed diagnosis of...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT06310967 · Intelligem Therapeutics Australia Pty Ltd. Phase 2 · 2 countries Recruiting
Recruiting Phase 2 Est. completion 1 July 2026
🇦🇺 AU🇹🇼 TW

**Who might be able to join this trial:** - Adults aged 18 to 75 years (men or women). - For Part 1 only: People whose kidneys are working at a normal or near-normal level (no chronic kidney disease), based on a kidney function measurement called eGFR being 60 or above. - For Part 2 only: People with moderate-to-sever...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT06531824 · Boehringer Ingelheim Phase 3 · 20 countries Recruiting
Recruiting Phase 3 Est. completion 30 August 2028
🇦🇷 AR🇦🇺 AU🇧🇪 BE🇧🇷 BR🇨🇦 CA🇨🇳 CN🇩🇰 DK🇩🇪 DE +12 more

**Who might be able to join this trial:** - You have been diagnosed with chronic kidney disease (CKD) that is at risk of getting worse, confirmed by blood and urine tests done at least 3 months apart. - Your kidney function test results fall into one of two ranges: either your kidneys are working at a low-to-moderate l...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT06717698 · Novo Nordisk A/S Phase 2 · 14 countries Recruiting
Recruiting Phase 2 Est. completion 1 September 2026
🇦🇷 AR🇦🇺 AU🇧🇷 BR🇧🇬 BG🇨🇿 CZ🇮🇳 IN🇮🇹 IT🇯🇵 JP +6 more

**Who might be able to join this trial:** - Women who are not able to become pregnant, or men. (In the US only, women who are able to become pregnant may also be considered if they have been using a highly effective, non-hormonal, low user-dependency form of contraception for at least 2 months before screening and agr...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT07107945 · Boehringer Ingelheim Phase 3 · 18 countries Recruiting
Recruiting Phase 3 Est. completion 26 June 2028
🇦🇷 AR🇦🇺 AU🇧🇪 BE🇨🇦 CA🇫🇷 FR🇩🇪 DE🇭🇺 HU🇮🇹 IT +10 more

**Who might be able to join this trial:** - A parent or legal guardian (and the child, where appropriate for their age and understanding) must agree to take part by signing a consent form before the trial begins. - Children and teenagers aged 2 to 17 years old at the time of the first screening visit. - Has chronic ki...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT07231679 · Ingenia Therapeutics INC Phase 2 · 2 countries Recruiting
Recruiting Phase 2 Est. completion 1 October 2026
🇦🇺 AU🇳🇿 NZ

**Who might be able to join this trial:** - People aged 18 to 75 years old at the time of the initial screening visit - People who are able to understand what the study involves and are willing to sign a written consent form - People whose body weight falls within a healthy-to-moderately-overweight range (a body mass...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 NCT07577817 · Cajal Therapeutics Inc. Early Phase 1 · 1 country Recruiting
Recruiting Early Phase 1 Est. completion 1 October 2026
🇦🇺 AU

**Who might be able to join this trial:** - People who are able to give their informed consent to participate - People who agree to use effective contraception during the trial - People whose Body Mass Index (BMI) falls between 18.0 and 32.0 - People who are considered healthy based on a medical check-up and medical hi...

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.
🇦🇺 NCT03608033 · Omeros Corporation Phase 3 · 23 countries Terminated
Terminated Phase 3 Est. completion 12 January 2024
🇦🇷 AR🇦🇺 AU🇧🇪 BE🇧🇬 BG🇨🇦 CA🇨🇿 CZ🇩🇪 DE🇬🇷 GR +15 more

**Who might be able to join this trial:** - You are 18 years of age or older at the time of screening - You have been diagnosed with IgA nephropathy (a kidney disease), confirmed by a biopsy taken within the last 8 years - Your medical records show a significant level of protein in your urine within the last 6 months,...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT00001979 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDD... Not Applicable · 1 country Recruiting
Recruiting Not Applicable
🇺🇸 US

Who might be able to join this trial: - People aged 18 or older, or children aged 10 to 17 years old - People who have a known, proven, or suspected kidney disease that involves the immune system, such as nephrotic syndrome, glomerulonephritis, membranous nephropathy, lupus nephritis, or kidney inflammation linked to o...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT00327860 · Johns Hopkins Bloomberg School of Public Health Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2028
🇺🇸 US

**Who might be able to join this trial:** - Children aged 1 to 16 years (for Cohorts 1 and 2), children aged 6 months to 16 years (for Cohort 3), or young people aged 16 to 22 years (for Cohort 4) - People with a measured level of kidney function (called GFR) that falls within a specific range depending on which cohor...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT00381121 · University of Michigan Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2030
🇺🇸 US

Who might be able to join this trial: - Men, women, and children who are having a kidney and/or pancreas biopsy performed at the University of Michigan. Who may not be able to join: - People who are not willing to give their consent to take part (for those having a biopsy in the future). Important: Always verify elig...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT01016613 · University of Michigan Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2030
🇺🇸 US

Who might be able to join this trial: - People of any age who have chronic kidney disease, which may be shown by an unusually high amount of protein in the urine or reduced kidney function found through blood tests - A small number of people who do not have chronic kidney disease Who may not be able to join: - People...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT01886950 · Universitaire Ziekenhuizen KU Leuven Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇧🇪 BE

Who might be able to join this trial: - Adults over 18 years old who have been assessed as suitable candidates for a kidney transplant Who may not be able to join: - People who have taken a type of bone medication called bisphosphonates at any point in the 6 months before joining the study Important: Always verify el...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT01893710 · Heidelberg University Not Applicable · 15 countries Recruiting
Recruiting Not Applicable Est. completion 1 October 2028
🇦🇹 AT🇧🇪 BE🇨🇿 CZ🇫🇷 FR🇩🇪 DE🇭🇺 HU🇮🇹 IT🇱🇹 LT +7 more

Who might be able to join this trial: - People aged 0 to 90 years old - People with advanced kidney disease (stage 5) who are on peritoneal dialysis (a type of dialysis done through the abdomen) - People with normal kidney function who are scheduled for planned abdominal surgery for a minor condition, such as a hernia...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02813642 · University Hospital, Montpellier Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇫🇷 FR

Who might be able to join this trial: - People who have signed the written consent form for the trial - People with chronic kidney failure who have started dialysis treatment Who may not be able to join: - People who are pregnant - People with chronic kidney failure who have not yet started dialysis treatment Importa...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02938611 · Centre Hospitalier Universitaire de Nīmes Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇫🇷 FR

"Who might be able to join this trial: - People who have been diagnosed with chronic kidney disease at stage 4 or higher (this means the kidneys are working at a significantly reduced level) Who may not be able to join: - No specific exclusion criteria have been listed for this trial (confirm with trial site) Importa...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02986984 · University of Pennsylvania Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
🇺🇸 US

Who might be able to join this trial: - People who have been diagnosed with Type 1 or Type 2 diabetes, according to American Diabetes Association standards. - People who are willing to follow the study's requirements, including attending follow-up appointments at a clinical study site as outlined in the study plan. - P...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02989298 · Sun Yat-sen University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇨🇳 CN

Who might be able to join this trial: - People who have Parkinson's disease (PD) Who may not be able to join: - No specific exclusion criteria have been listed in the available information (confirm with trial site) Important: Always verify eligibility with the trial site directly before applying.

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03032835 · Massachusetts General Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2030
🇺🇸 US

Who might be able to join this trial: - People who are 18 years of age or older - People who have skin lesions (wounds or sores) that a treating doctor has identified as consistent with a condition called calciphylaxis - People who have been informed about the research nature of the study and have signed a written cons...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03321656 · Roberto Gedaly Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 31 March 2027
🇺🇸 US

**Who might be able to join this trial:** - People who are fluent in English and can understand and agree to the study terms in writing - People who have end-stage kidney disease and are listed to receive their first kidney transplant (a single kidney, not a second transplant) - People who are willing to follow all stu...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT03471117 · The University of Texas at Arlington Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 April 2026
🇺🇸 US

**Who might be able to join this trial:** - People who have been diagnosed with chronic kidney disease classified as Stage 3 or 4, with kidney function test results (called GFR) falling between 15 and 59 mL/min/1.73 m² - People who are between 35 and 70 years of age (men and women) **Who may not be able to join:** - P...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT03619850 · AMAG Pharmaceuticals, Inc. Phase 3 · 5 countries Recruiting
Recruiting Phase 3 Est. completion 31 August 2026
🇭🇺 HU🇱🇹 LT🇲🇽 MX🇵🇱 PL🇺🇸 US

**Who might be able to join this trial:** - Children aged 2 years up to (but not including) 18 years old at the time of consent - People with low iron levels in their blood, shown by either a haemoglobin level below 12.0 g/dL combined with low iron stores, or those considered at risk of developing low iron levels base...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT03633708 · Amgen Phase 3 · 10 countries Recruiting
Recruiting Phase 3 Est. completion 31 January 2029
🇦🇷 AR🇮🇳 IN🇲🇾 MY🇷🇺 RU🇸🇬 SG🇰🇷 KR🇹🇼 TW Turkey (Türkiye) +2 more

**Who might be able to join this trial:** - Children aged from 28 days old up to (but not including) 18 years old. - Children who weigh at least 7 kg (approximately 15.4 lbs) at the time of screening. - Children who have been diagnosed with chronic kidney disease (CKD) and a condition called secondary hyperparathyroid...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT03711617 · Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong Univ... Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2024
🇨🇳 CN

Who might be able to join this trial: - Adults aged 18 years or older. - People who have been clinically diagnosed with chronic kidney disease, based on a set of medical guidelines called K/DOQI criteria. Who may not be able to join: - People who are currently experiencing a sudden or recent loss of kidney function (k...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03716128 · Ditte Hansen Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2027
🇩🇰 DK

**Who might be able to join this trial:** **Group 1 – People with reduced kidney function:** - Adults aged 18 or older - People whose kidneys are functioning at a very low level, based on a specific kidney test result (eGFR of 20 or below) (confirm with trial site) - People whose parathyroid hormone (a hormone that he...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03929900 · Seoul National University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇰🇷 KR

**Who might be able to join this trial:** - You are between 45 and 79 years old - Your kidneys are working at a reduced level, based on a specific blood test result that your doctor can check (a score between 20 and 60 on a kidney function scale) - You are not currently on dialysis **Who may not be able to join:** - Y...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03969329 · Amgen Phase 3 · 12 countries Recruiting
Recruiting Phase 3 Est. completion 30 June 2027
🇧🇪 BE🇨🇿 CZ🇫🇷 FR🇩🇪 DE🇬🇷 GR🇭🇺 HU🇮🇹 IT🇱🇹 LT +4 more

Who might be able to join this trial: - A parent or legal guardian must have given written consent, and the child must have given written agreement to participate, before any trial activities begin. - Children and teenagers aged 2 years old up to (but not including) 18 years old at the time of joining. - The child's ta...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT03979534 · Centre Hospitalier le Mans Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2028
🇫🇷 FR

Who might be able to join this trial: - Adults being treated at the unit for advanced chronic kidney disease, specifically those with kidney disease at stage 4 or 5, or stage 3 with rapid worsening, and without any medical reasons that would prevent participation Who may not be able to join: - People who are malnouris...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03991169 · Weill Medical College of Cornell University Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 31 December 2028
🇺🇸 US

Who might be able to join this trial: - Children and young people between 1 and 21 years old (muscle strength testing is only done for those older than 3 years) - People whose kidneys are working at a reduced level, measured by a specific formula using height and a blood test result called creatinine - People whose mos...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT03994471 · Iperboreal Pharma Srl Phase 3 · 6 countries Recruiting
Recruiting Phase 3 Est. completion 31 December 2026
🇩🇰 DK🇩🇪 DE🇮🇹 IT🇪🇸 ES🇸🇪 SE🇬🇧 GB

Who might be able to join this trial: - People aged 18 or older - People who have been diagnosed with end-stage kidney failure (where the kidneys no longer work) and have been treated with a specific type of home dialysis called CAPD (fluid-based dialysis through the abdomen) for the past 3 months - People who have bee...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT04044963 · University of British Columbia Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2026
🇨🇦 CA

**Who might be able to join this trial:** - People who are physically able to take part in a home-based exercise program and complete all physical tests required by the study - People who can read and write in English well enough to fill out study questionnaires - People aged 19 or older, of any gender - People who are...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04098354 · University of Alberta Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇨🇦 CA

**Who might be able to join this trial:** - Adults aged 18 or older who have a confirmed diagnosis of chronic kidney disease (CKD) that is not being treated with dialysis, with kidney function or protein levels in the urine that meet specific medical thresholds (confirm with trial site) - People who live in remote area...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04128189 · University of Colorado, Denver Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 June 2029
🇺🇸 US

**Who might be able to join this trial:** - Adults between 18 and 70 years of age - People who are willing and able to sign a written consent form - People who are currently on a kidney transplant waiting list at one of the participating hospitals, with their transplant expected to happen between 3 and 24 months after...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT04160507 · Duke University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 November 2026
🇺🇸 US

**Who might be able to join this trial:** - People who self-identify as African American, Afro-Caribbean, or other Black individuals, at various stages of kidney disease or with no signs of kidney disease - Healthy Black adults aged 50 or older with no known history of kidney disease (recruited as controls) **Who may...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04163614 · VA Office of Research and Development Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2026
🇺🇸 US

**Who might be able to join this trial:** - People who are currently receiving hemodialysis (kidney dialysis treatment) - People whose average blood pressure reading before dialysis is above 140 mmHg (the top number) over a 2-week period, OR whose average blood pressure reading after dialysis is above 130 mmHg over a 2...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04180085 · Nantes University Hospital Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 January 2028
🇫🇷 FR

**Who might be able to join this trial:** - People who received a heart transplant at least 3 months ago - People who are 18 years of age or older - People who do not have donor-specific antibodies (proteins that could attack the transplanted heart) at the time of joining the trial - People whose kidney function is sig...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT04185844 · University of New Mexico Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2028
🇺🇸 US

Who might be able to join this trial: - People whose kidneys are filtering at a moderately reduced level (a kidney function score between 61 and 79) AND who also have a small but above-normal amount of protein in their urine, OR people whose kidneys are filtering at a more significantly reduced level (a kidney function...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04212923 · Leiden University Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2025
🇨🇳 CN

Who might be able to join this trial: - People who are over 18 years old - People who have been diagnosed with chronic kidney disease (a long-term condition where the kidneys do not work as well as they should) - People who speak Chinese - Healthcare providers (such as doctors or nurses) who work in a kidney disease (N...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04330729 · Zealand University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇩🇰 DK

**Who might be able to join this trial:** - People aged 18 to 85 years old - People who are on long-term kidney dialysis (either hemodialysis or peritoneal dialysis) or who have severe chronic kidney disease managed without dialysis - People whose doctors have determined that treatment with a type of medication that s...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04381143 · Guangdong Provincial People's Hospital Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 September 2026
🇨🇳 CN

**Who might be able to join this trial:** - You are 18 years old or older and currently on dialysis (either newly started or already established on dialysis). - You are expected to need ongoing, long-term dialysis treatment. - You are willing and able to give your consent to take part in this study. **Who may not be a...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT04392206 · Houssam Farres, M.D. Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 1 December 2026
🇺🇸 US

Who might be able to join this trial: - You are between 18 and 85 years old - Your doctor has planned for you to have an arteriovenous (AV) fistula created in your arm, and your anatomy is suitable for this procedure - You are able to communicate with the research team, can give written consent, and are willing and abl...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT04397159 · VA Office of Research and Development Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2027
🇺🇸 US

Who might be able to join this trial: - People aged 50 or older who are able to walk (with or without a walking aid) and have been diagnosed with moderate-to-severe chronic kidney disease (stages 3 or 4, not yet on dialysis), based on a specific kidney function measurement - People aged 50 or older who are able to walk...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04404114 · National Taiwan University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇹🇼 TW

Who might be able to join this trial: - People older than 20 years old who need to have a kidney ultrasound done in the emergency department at National Taiwan University Hospital. Who may not be able to join: - People who do not give their agreement to take part in the trial. - People who are unable to cooperate or f...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04522622 · Ditte Hansen Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 September 2026
🇩🇰 DK

**Who might be able to join this trial:** - People aged 18 years or older. - People with advanced chronic kidney disease (stage 4 or 5, including those on dialysis), meaning the kidneys are working at 29% or less of normal function. - People whose bone density scan (DXA) shows significantly low bone density at the hip...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT04522765 · University of Edinburgh Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇬🇧 GB

Who might be able to join this trial: - People who attend NHS Lothian inpatient or outpatient services and are considered to be at increased risk of cardiovascular disease (heart and blood vessel problems) - People who have chronic kidney disease (long-term reduced kidney function), as classified by an established medi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04580420 · Dicerna Pharmaceuticals, Inc., a Novo Nordisk company Phase 2 · 10 countries Recruiting
Recruiting Phase 2 Est. completion 30 December 2031
🇫🇷 FR🇩🇪 DE🇮🇹 IT🇱🇧 LB Morocco🇷🇴 RO🇪🇸 ES🇦🇪 AE +2 more

Who might be able to join this trial: - People from birth up to age 5 are currently being enrolled (the trial notes that only participants under 6 years of age are being accepted at this time). - People who have been formally diagnosed with a condition called Primary Hyperoxaluria Type 1 (PH1), confirmed through geneti...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT04626167 · Mayo Clinic Early Phase 1 · 1 country Recruiting
Recruiting Early Phase 1 Est. completion 1 August 2026
🇺🇸 US

**Who might be able to join this trial:** - People between 1 and 60 years of age (male or female). - People who are willing and able to give signed agreement to take part, or who have a legally authorised representative who can do so on their behalf. Children aged 6–17 may also be asked to give their own agreement whe...

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.
NCT04671771 · W.L.Gore & Associates Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇺🇸 US

**Who might be able to join this trial:** - People with end-stage kidney disease (kidneys have stopped working) who need a new or replacement connection between an artery and vein (called an AV graft) in their arm to allow for dialysis treatment - People aged 18 to 90 years old - People whose arm anatomy is suitable f...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04708587 · Yonsei University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 13 March 2027
🇰🇷 KR

**Who might be able to join this trial:** - People who are over 19 years old - People who have moderate to advanced chronic kidney disease (specifically stages 3b, 4, or 5, including those on dialysis) - People who have been treated with a newer type of heart stent called a drug-eluting stent - People who have signed a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04741646 · University of California, Los Angeles Phase 2 · 2 countries Recruiting
Recruiting Phase 2 Est. completion 1 October 2027
🇨🇦 CA🇺🇸 US

Who might be able to join this trial: - Children and teenagers between 6 and 18 years old (inclusive) - People whose kidneys are working at a reduced level, measured by a specific kidney function test called GFR, falling between 15 and 59 ml/min per 1.73 m² using a formula designed for children - People whose blood pho...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT04759274 · University of Texas Southwestern Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2026
🇺🇸 US

**Who might be able to join this trial:** - People who have high levels of protein in their urine (above a certain threshold, measured by a urine test) OR have significantly reduced kidney function (stage 4 or 5 chronic kidney disease), AND - People who are showing signs of fluid build-up in their body — such as swell...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04819217 · National Taiwan University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2030
🇹🇼 TW

Who might be able to join this trial: - People who are 20 years of age or older at the time of screening. - People who have chronic kidney disease with kidney function and protein-in-urine levels within a specific range, and whose kidney function has been stable for at least 30 days before joining the trial. Who may n...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04984226 · University of California, Davis Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 31 December 2026
🇺🇸 US

**Who might be able to join this trial:** - People who have moderate-to-severe chronic kidney disease, shown by kidney function test results below a certain level on at least two separate occasions - People who have a blood acid-base imbalance called metabolic acidosis, confirmed by blood test results on two separate...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05014178 · London Health Sciences Centre Research Institute OR Lawson Research In... Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇨🇦 CA

Who might be able to join this trial: - You must be 18 years of age or older - If you are a healthy volunteer (no known kidney, heart, or liver problems), you should not have kidney disease, heart failure, liver scarring, or swelling caused by fluid buildup in the legs or body - If you have chronic kidney disease (CKD)...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05036850 · George (Beijing) Clinical Research Co. Ltd. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 September 2026
🇨🇳 CN

Who might be able to join this trial: - You have been officially diagnosed with a primary kidney disease - You have regular check-ups (at least every 6 months) with a doctor at one of the participating clinics - Your kidneys are still working at a level above a certain threshold, measured by a blood test called eGFR be...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05090865 · University of Manitoba Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2026
🇨🇦 CA

Who might be able to join this trial: - People aged 18 years or older, of any sex - People whose kidneys are working at a reduced but not critically low level, with a kidney function score (eGFR) between 15 and 45 ml/min/1.73m² - People with a blood potassium level between 4.5 and 5.5 mEq/L - People with a blood sugar...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05106387 · Regeneron Pharmaceuticals Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 14 June 2027
🇺🇸 US

Who might be able to join this trial: - People who received at least one dose of a medicine called vonsetamig as part of a previous clinical trial (NCT05092347, also called study R5459-RT-1944) - People who received a kidney transplant during that previous trial, after a compatibility matching process was completed - P...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05117450 · CHU de Reims Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 17 November 2026
🇫🇷 FR

**Who might be able to join this trial:** - Adults older than 18 years of age - People who have been receiving hemodialysis (a type of kidney treatment that filters the blood) for at least 3 months - People who receive hemodialysis three times per week - People who receive a blood-thinning medication called heparin dur...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05149196 · Peking University First Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2032
🇨🇳 CN

Who might be able to join this trial: - You are 18 years old or older - You are scheduled to have surgery to remove one kidney due to kidney cancer, or to remove one kidney and its connecting tube (ureter) due to a type of cancer called upper tract urothelial carcinoma Who may not be able to join: - You have been diag...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05188885 · Guangdong Provincial People's Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 27 December 2026
🇨🇳 CN

Who might be able to join this trial: - People who have been diagnosed with chronic kidney disease (CKD), as defined by international kidney disease guidelines from 2012 - People who do not have CKD but do have one or more risk factors for developing it, such as high blood pressure, diabetes, high cholesterol, or high...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05204212 · Prof. Dr. med. Ingo Eitel Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 14 January 2026
🇩🇪 DE

**Who might be able to join this trial:** - Adults aged 18 or older - People who are able to give their informed consent to participate - People who have been diagnosed with a type of irregular heartbeat called non-valvular atrial fibrillation (AF), whether it comes and goes, has lasted a long time, or is permanent - P...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05249634 · St. Louis University Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 June 2028
🇺🇸 US

**Who might be able to join this trial:** - Men between 18 and 85 years old - Men whose kidneys are working at a reduced level, with a specific kidney function score (eGFR) between 15 and 45 ml/min/1.73m² as measured by a standard formula called MDRD (confirm with trial site) - Men who have had two separate morning bl...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05266092 · Odense University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2023
🇩🇰 DK

**Who might be able to join this trial:** This trial has four separate groups. People may be considered for one of the following groups: **Group 1 – People with chronic kidney disease on hemodialysis:** - Adults aged 18 or older who have chronic kidney disease (long-term kidney disease) and are currently receiving he...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05282732 · Fresenius Medical Care Deutschland GmbH Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇩🇪 DE

Who might be able to join this trial: - People with kidney failure who needed a blood-cleaning treatment (a machine that filters the blood outside the body) and received all of their treatments using the specific devices being studied, between January 2019 and December 2019 — records must be available in the order the...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05283512 · Odense University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇩🇰 DK

Who might be able to join this trial: - Your kidneys are not working well, specifically filtering at a low level (a blood test result called eGFR is below 30) — confirm with trial site if unsure - You are already scheduled to have a planned CT scan that uses an injected dye (contrast dye given through a vein) - You are...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05325099 · National Taiwan University Hospital Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 31 December 2025
🇹🇼 TW

Who might be able to join this trial: - People who have developed moderate to severe kidney injury (stages 2 or 3) as a result of heart surgery Who may not be able to join: - People who have long-term (chronic) kidney disease - People whose heart is not pumping well enough (with an ejection fraction below 45%, meaning...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05326399 · RenJi Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2027
🇨🇳 CN

Who might be able to join this trial: - People aged between 18 and 75 years old - People who have previously received a liver transplant - People who have developed new protein in their urine (measured on at least two separate occasions) and/or a decline in kidney function (measured on at least two separate occasions)...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05353660 · Nanfang Hospital, Southern Medical University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇨🇳 CN

**Who might be able to join this trial:** - You are 18 years old or older, but younger than 80 years old - Your kidneys are not working well (a blood test shows reduced kidney function below a certain level), OR you have been on regular dialysis for at least 3 months **Who may not be able to join:** - You have a muscl...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05353946 · Guillermo Galeote; MD, PhD Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 27 December 2022
🇪🇸 ES

**Who might be able to join this trial:** - You must be over 18 years old - Your kidneys must have been working at a reduced level (less than 60% of normal function) for at least 3 months - You must have a significant blockage (70% or more) in at least one heart artery that is large enough to be treated (confirm with t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05356325 · Maimónides Biomedical Research Institute of Córdoba Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2025
🇪🇸 ES

**Who might be able to join this trial:** - People whose hemoglobin blood level is below 11 g/dL (a measure that indicates low red blood cell levels) - People whose iron storage level in the blood (ferritin) is below 100 ng/ml, or whose transferrin saturation (a measure of how much iron is being carried in the blood) i...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05359263 · Tor Biering-Sørensen Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 18 February 2025
🇩🇰 DK

Who might be able to join this trial: - People aged 18 or older - People who have chronic kidney disease (CKD) with reduced kidney function, measured by a specific kidney test result falling within a certain range, or a moderately reduced kidney function with significant protein in the urine (confirm exact values with...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05410275 · University Hospital, Tours Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 30 January 2027
🇫🇷 FR

**Who might be able to join this trial:** - People aged 18 or older - People who have been receiving regular kidney dialysis (hemodialysis) for at least 3 months - People who are covered by a social security or health insurance plan - People who have read, understood, and signed a consent form agreeing to take part **...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05422534 · Vanderbilt University Medical Center Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 20 June 2027
🇺🇸 US

Who might be able to join this trial: - People between 18 and 75 years of age - People who have been receiving hemodialysis three times per week for at least 6 months (applies only to those with end-stage kidney disease on ongoing hemodialysis) - People whose condition is medically stable and whose dialysis has been wo...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05465044 · VA Office of Research and Development Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2027
🇺🇸 US

**Who might be able to join this trial:** - You are a Veteran aged 18 or older who has been diagnosed with end-stage kidney disease (kidney failure) and either will soon need to start regular dialysis, or have been on hemodialysis for no longer than 8 weeks at one of the six participating VA centers. - You meet specif...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05489120 · Dr. Schär AG / SPA Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2026
🇫🇷 FR

**Who might be able to join this trial:** - People who have chronic kidney disease (CKD) at a moderate to severe stage (stages 3a to 5), with kidney function below a certain level, and who are not currently on dialysis - People who have a good nutritional status — meaning no signs of malnutrition based on blood tests...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05510323 · Air Force Military Medical University, China Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 August 2025
🇨🇳 CN

Who might be able to join this trial: - People who have been diagnosed with IgA nephropathy (a kidney disease) confirmed by a biopsy (a small tissue sample taken from the kidney). - People who have a significant amount of protein leaking into their urine (at least 1.0g per day) even while taking the highest tolerable d...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05515367 · Zydus Lifesciences Limited Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 30 June 2025
🇮🇳 IN

**Who might be able to join this trial:** - Adults aged 18 or older, of any gender - People who have been diagnosed with anaemia caused by chronic kidney disease (CKD), with a haemoglobin level between 7.0 and 11.0 g/dL at the start of the trial - People who are able to understand the study information and agree to ta...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT05525507 · University of California, Los Angeles Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 1 December 2026
🇺🇸 US

**Who might be able to join this trial:** **For the kidney transplant recipient (the patient):** - Adults aged 18 or older who have already received a kidney transplant from a living donor whose tissue type (HLA) closely matches theirs - The kidney transplant was received between 3 months and 5 years before the planne...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05527626 · University Hospital, Strasbourg, France Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2027
🇫🇷 FR

"Who might be able to join this trial: - People who are 18 years of age or older - People whose kidneys are working at a reduced level, specifically with a kidney filtration rate below 30 ml/min/1.73 m² (a measurement of how well the kidneys filter waste from the blood), which places them in a specific kidney care prog...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05546099 · VA Office of Research and Development Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 30 September 2026
🇺🇸 US

**Who might be able to join this trial:** - Adults aged 18 or older - People who have moderate-to-moderately-severe kidney disease (known as CKD stage 3 or 4), where the kidneys are filtering at a reduced but not critically low level - People who have mild kidney disease (CKD stage 2) with high levels of a protein call...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05562869 · Nantes University Hospital Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 3 May 2027
🇫🇷 FR

**Who might be able to join this trial:** - Adults aged 18 or older - People who have received a kidney transplant from a deceased or living donor, where the donor and recipient are not a full genetic (HLA) match, and where blood types are compatible - People whose kidney function (measured by a specific calculation c...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05570929 · Charite University, Berlin, Germany Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2025
🇩🇪 DE

Who might be able to join this trial: - People with a Body Mass Index (BMI) between 18.5 and 34.9 (a measure of body weight relative to height that falls within a normal to overweight range) - People who are scheduled to donate or receive a kidney from a living donor Who may not be able to join: - People who have sign...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05612022 · Mario Negri Institute for Pharmacological Research Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇮🇹 IT

Who might be able to join this trial: - People who are willing and able to give their consent to take part before any study procedures begin. - People who are already on haemodialysis and need a new way to access their blood vessels for treatment, or people with end-stage kidney disease who are preparing to start dialy...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05642156 · Medical University of Graz Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇦🇹 AT

**Who might be able to join this trial:** - You must be willing and able to give written agreement to take part in the study - You must be at least 18 years old - You must have end-stage kidney failure and currently be receiving hemodialysis (a type of dialysis that cleans your blood using a machine) - Your body weight...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05654103 · University of California, Los Angeles Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇺🇸 US

**Who might be able to join this trial:** - Adults aged 18 or older who have end-stage kidney disease and have chosen hemodialysis as their kidney treatment method - People who are able to understand and give consent to take part in a research study - People whose upper arm vein measures at least 2.0 mm wide *For one...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05656261 · St. Louis University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2026
🇺🇸 US

Who might be able to join this trial: - Adults between 18 and 90 years old. - People who self-identify as Black or African American, including those of African ancestry who identify as multiracial. Who may not be able to join: - People who have a cognitive impairment or are otherwise unable to give their own consent t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05679024 · Region Stockholm Phase 3 · 4 countries Recruiting
Recruiting Phase 3 Est. completion 31 December 2027
🇫🇮 FI Iceland🇳🇴 NO🇸🇪 SE

**Who might be able to join this trial:** - People aged 18 or older - People who have signed a written consent form to take part in the study - People who are currently on ongoing dialysis treatment, OR whose kidney function test results (called eGFR) show a reading below 20 on at least two separate occasions at least...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05719714 · Northwestern University Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 30 September 2026
🇺🇸 US

Who might be able to join this trial: - People who are older than 18 years of age - People whose kidneys are working at a reduced but not severely low level (a specific kidney function test score between 25 and 60, which a doctor can measure) - People who have been on stable, unchanged doses of water pills (diuretics)...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05726526 · University of Manitoba Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 March 2027
🇨🇦 CA

Who might be able to join this trial: - People who are over 18 years of age - People whose patient or main carer can read and speak English - People whose patient or substitute decision maker is able to give informed consent to participate - People whose patient or main carer is mentally and physically able and willing...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05728216 · Centre Hospitalier William Morey - Chalon sur Saône Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 October 2028
🇫🇷 FR

Who might be able to join this trial: - Adults over 18 years old who are suspected to have sudden (acute) kidney injury and need a kidney biopsy in the nephrology (kidney) department - Adults over 18 years old who are suspected to have long-term (chronic) kidney disease and need a kidney biopsy in the nephrology (kidne...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05732727 · University Hospital, Tours Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 March 2029
🇫🇷 FR

**Who might be able to join this trial:** - You are 18 years old or older (if you are over 80, you must also be assessed as not severely frail, based on a standard frailty scoring tool) - You have moderate or advanced chronic kidney disease, based on a specific kidney function measurement (eGFR between 15 and 44.9, co...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05738330 · University of Pennsylvania Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2027
🇺🇸 US

Who might be able to join this trial: - People who are 18 years of age or older - People who are currently receiving hemodialysis treatment at one of the participating dialysis clinics - People who speak English or Spanish Who may not be able to join: - People who are not willing to report their symptoms using the SMa...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05738525 · Chinese PLA General Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
🇨🇳 CN

**Who might be able to join this trial:** - People aged between 18 and 75 years old - People who have been diagnosed with end-stage renal disease (kidney failure) - People whose kidneys' filtering membranes move waste products into the dialysis fluid at a faster-than-average rate, based on a standard test result (conf...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05753020 · University of Washington Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2024
🇺🇸 US

Who might be able to join this trial: - Adults who are 75 years of age or older - People with advanced chronic kidney disease, meaning their kidney function tests (called eGFR) have shown readings below 25 on at least two separate occasions more than 90 days apart in the past year, with at least one reading below 20 -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05753930 · Hansa Biopharma AB Phase 2 · 5 countries Recruiting
Recruiting Phase 2 Est. completion 28 February 2027
🇫🇮 FI🇫🇷 FR🇪🇸 ES🇸🇪 SE🇬🇧 GB

**Who might be able to join this trial:** - A parent, legal guardian, or independent witness (depending on the child's age) has signed a consent form before any trial-related steps begin. - The patient has very high levels of antibodies that make transplant matching difficult, with a panel reactive antibody (PRA) leve...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05786443 · NYU Langone Health Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 30 December 2026
🇺🇸 US

**Who might be able to join this trial:** - Adults aged 18 or older who are on maintenance hemodialysis three times per week and still produce some urine - People who are willing and able to give informed consent to participate - Women who could become pregnant must have a negative pregnancy test at the screening stag...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05828823 · Wake Forest University Health Sciences Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2030
🇺🇸 US

**Who might be able to join this trial:** **For patients:** - Adults aged 18 or older - People who have recently started, or are expected to start within the next 12 weeks, regular in-centre haemodialysis (a type of kidney dialysis done at a clinic) due to kidney failure - People who have had no more than 36 haemodial...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05852704 · Region Örebro County Phase 3 · 3 countries Recruiting
Recruiting Phase 3 Est. completion 4 December 2027
🇨🇿 CZ🇩🇰 DK🇸🇪 SE

Who might be able to join this trial: - People aged 18 years or older. - People who have chronic coronary syndrome (a long-term heart condition affecting blood supply) and are scheduled for planned, non-emergency heart bypass surgery (CABG) using a heart-lung machine, either on its own or combined with aortic valve rep...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05878171 · National Taiwan University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 April 2025
🇹🇼 TW

Who might be able to join this trial: - You are over 20 years old. - You have been diagnosed with severe chronic kidney disease (stage 5) or end-stage kidney failure, with kidneys functioning at less than 15% of normal capacity, OR you are already receiving regular dialysis treatment (either haemodialysis or peritoneal...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05880537 · LifeNet Health Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 December 2027
🇺🇸 US

**Who might be able to join this trial:** - People who are 18 years of age or older at the time the graft is placed - People who have been diagnosed with end-stage kidney disease or serious kidney problems that require hemodialysis (a machine-based blood-cleaning treatment) - People who need a new way to access their...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05880914 · Thomas Nickolas Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2027
🇺🇸 US

**Who might be able to join this trial:** - You are 18 years old or older - You have been diagnosed with chronic kidney disease (CKD) at stage 3, 4, or 5, with or without a kidney transplant - If you are on dialysis (hemodialysis), you have been receiving it regularly for at least 3 months - Your doctor has determined...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05881447 · Swiss Tropical & Public Health Institute Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
Tanzania

Who might be able to join this trial: - Adults aged 18 or older who are attending outpatient services at Bagamoyo District Hospital, or the associated Fukayosi or Yombo dispensary Who may not be able to join: - People under 18 years of age - People who do not live within the Bagamoyo District Hospital catchment area -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05917795 · Fondazione Policlinico Universitario Agostino Gemelli IRCCS Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2027
🇮🇹 IT

**Who might be able to join this trial:** - Adults between 18 and 70 years of age - People with a Body Mass Index (BMI) of 35 or higher (a measure of body weight relative to height) - People with serious kidney disease where the kidneys are working at less than 30% of normal function, and who are expected to reach comp...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05918029 · Albert Einstein College of Medicine Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 August 2026
🇺🇸 US

**Who might be able to join this trial:** **For children (ages 5–17):** - Children between 5 and 17 years old - Children whose kidneys are working at a reduced but not severely low level, based on a specific kidney function calculation (confirm with trial site) - Girls who could become pregnant must have had a menstru...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05918523 · Prokidney Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2028
🇺🇸 US

Who might be able to join this trial: - You must have already received a treatment called REACT (a gelatin-hydrogel formula) in a previous clinical trial (one of these: RMCL-002, REGEN-003, or REGEN-004) for chronic kidney disease, and completed all required visits in that trial. Who may not be able to join: - You did...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05928936 · Emory University Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 June 2028
🇺🇸 US

**Who might be able to join this trial:** - People who have moderate-to-moderately-severe chronic kidney disease (CKD Stages 3 or 4), people who have received a kidney transplant with any level of kidney function, or people without kidney disease who are participating as comparison subjects - People who are not curren...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05931276 · VA Office of Research and Development Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 31 December 2026
🇺🇸 US

Who might be able to join this trial: - You are currently receiving hemodialysis (a kidney treatment that filters your blood using a machine) - You have been prescribed one of these heart/blood pressure medications through a VA pharmacy: metoprolol (succinate or tartrate), atenolol, labetalol, carvedilol, or bisoprolol...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05942027 · Tanta University Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 14 July 2026
🇪🇬 EG

**Who might be able to join this trial:** - Adults aged 18 or older, of any sex - People whose chronic kidney disease (CKD) diagnosis timing matches the study's requirements - People with CKD who are not currently on dialysis, with kidney function falling within a specific moderate range (Stage 2 to 3b, as measured by...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT05942053 · Tanta University Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 14 July 2026
🇪🇬 EG

**Who might be able to join this trial:** - Adults aged 18 or older, of any sex - People whose chronic kidney disease (CKD) has been present for a similar duration to other participants (matched for comparison purposes) - People with CKD who are not on dialysis, and whose kidneys are functioning at a moderate level —...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT05944016 · University Hospital Goettingen Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 September 2026
🇩🇪 DE

Who might be able to join this trial: - People who have been diagnosed with Alport syndrome (a kidney disease) at the start of the trial screening process. - Teenagers aged 10 to under 18 who have high levels of protein in their urine (a urine test result of 300mg/g creatinine or above) and whose kidneys are still func...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05963126 · University Hospital Ostrava Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇨🇿 CZ

**Who might be able to join this trial:** - People who have high blood pressure (hypertension) and are currently taking at least one medication to treat it **Who may not be able to join:** - People who have diabetes of any type, indicated by certain blood sugar or HbA1c test results above specific levels - People whos...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05970172 · Astellas Pharma Global Development, Inc. Phase 3 · 22 countries Recruiting
Recruiting Phase 3 Est. completion 30 October 2027
🇧🇪 BE🇧🇬 BG🇭🇷 HR🇨🇿 CZ🇩🇰 DK🇫🇮 FI🇩🇪 DE🇬🇷 GR +14 more

**Who might be able to join this trial:** - People who have been diagnosed with anemia related to chronic kidney disease (CKD) at stages 3, 4, or 5 — including those who are not on dialysis, as well as those receiving hemodialysis, peritoneal dialysis, or hemodiafiltration. - People not on dialysis whose kidneys are f...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05970341 · University of Texas at Austin Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2026
🇺🇸 US

**Who might be able to join this trial:** - Adults aged 18 or older - People who receive primary care at one of three Harris Health clinics: Smith Clinic, Harris Health Outpatient Center (on the LBJ campus), or Martin Luther King Jr. Health Center (MLK) - People who have had at least one visit at the clinic in the pas...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05981183 · NYU Langone Health Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 7 January 2026
🇺🇸 US

**Who might be able to join this trial:** - Adults between 18 and 80 years of age who have chronic kidney disease at stage 3, 4, or 5, meaning their kidneys are working at less than 60% of normal capacity based on a recent blood test done outside of hospital. **Who may not be able to join:** - People whose heart depen...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05997875 · University of Pennsylvania Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2027
🇺🇸 US

**Who might be able to join this trial:** - People who are 18 years of age or older - People who have had a nephrology (kidney specialist) visit for chronic kidney disease within the last 18 months - People whose most recent kidney function test shows significantly reduced kidney function, or whose calculated risk of k...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06001827 · VenoStent Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
🇺🇸 US

**Who might be able to join this trial:** - People who are 18 years of age or older - People who have been referred to have a new arteriovenous fistula (AVF) — a surgically created connection between an artery and vein, often used for dialysis access — created for the first time - People who are willing and able to fol...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06013865 · VA Office of Research and Development Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 31 March 2030
🇺🇸 US

**Who might be able to join this trial:** - You must be an adult (over 18 years old) of any gender, race, or ethnicity - You must be able to understand the study information and give your written consent to participate - You must have received your first or second kidney transplant at least 3 months ago - If you have...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06032208 · London Health Sciences Centre Research Institute OR Lawson Research In... Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇨🇦 CA

Who might be able to join this trial: - People who receive hemodialysis (kidney dialysis) three times per week on a standard schedule - People who have been on regular hemodialysis for at least 3 months - People aged 18 years or older - People who are willing and able to give their formal agreement to take part in the...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06040281 · University of Erlangen-Nürnberg Medical School Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2026
🇩🇪 DE

Who might be able to join this trial: - You are currently on dialysis - You are 18 years of age or older - You own a smartphone - You are willing to take part in an inpatient rehabilitation program during the study period - You are willing to sign a consent form agreeing to take part and allowing your data to be used...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06047106 · Hospices Civils de Lyon Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2029
🇫🇷 FR

**Who might be able to join this trial:** **For kidney transplant recipients:** - People with end-stage chronic kidney disease who are waiting to receive a kidney from a living donor - Adults (18 years or older) - People who have signed a consent form agreeing to take part - Women of childbearing age who are using an...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06051058 · Brigham and Women's Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
🇺🇸 US

**Who might be able to join this trial:** - People aged 55 or older who have a primary care doctor at Brigham (or an appointment at one of 15 specific locations) and are being discharged from a Brigham and Women's Hospital general medicine unit - People being discharged to their own home, a home health care service, o...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06065982 · Universitair Ziekenhuis Brussel Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 23 June 2026
🇧🇪 BE🇳🇱 NL

Who might be able to join this trial: - People who are older than 18 years of age - People who have had a peritoneal dialysis (PD) catheter inserted through the skin between March 1st 2023 and March 1st 2026 (enrollment may be possible from 4 weeks before up to 12 weeks after the catheter insertion) Who may not be abl...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06077747 · Mayo Clinic Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2027
🇺🇸 US

**Who might be able to join this trial:** - People who have had a daily headache every day since it started, lasting more than 3 months - People whose headache feels like a pressure sensation - People whose headache gets worse when lying with their head lower than their feet (such as in a tilted position) - People who...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06089057 · VA Office of Research and Development Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2028
🇺🇸 US

**Who might be able to join this trial:** - The participant's kidney specialist and/or regular doctor agrees that the person may take part in the trial - People who are considered "pre-frail" based on a walking speed test (taking more than 6 seconds to walk 15 feet), OR who answer "yes" to at least one of the following...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06089473 · McGill University Health Centre/Research Institute of the McGill Unive... Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2026
🇨🇦 CA

**Who might be able to join this trial:** - Adults aged 18 or older who have end-stage kidney disease (kidneys that have stopped working) and have been assessed as pre-frail, frail, or very frail using a standard frailty measurement tool called Fried's Frailty Phenotype - People who are on, or in the process of being...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06096142 · Scitech Produtos Medicos SA Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2026
🇧🇷 BR

**Who might be able to join this trial:** - People who have a working dialysis access point in their arm (either a surgically created connection between an artery and vein, called a fistula, or a synthetic tube called a graft) that was created at least 30 days before the study procedure and is currently being used for...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06109493 · Universidad Europea de Madrid Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇪🇸 ES

Who might be able to join this trial: - You have chronic kidney disease and are currently receiving haemodialysis (a treatment that filters your blood using a machine) - You are over 18 years old - You have been on haemodialysis for at least 3 months - You have scored 14 or higher on a questionnaire called the HADS (Ho...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06110130 · Washington D.C. Veterans Affairs Medical Center Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 December 2027
🇺🇸 US

**Who might be able to join this trial:** - You identify as African American and are a military veteran - You are older than 18 years of age - Your kidney function test results fall within a specific moderate range, showing either moderately reduced kidney function with or without protein in the urine, or mildly reduce...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06126016 · Boryung Pharmaceutical Co., Ltd Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2026
🇰🇷 KR

**Who might be able to join this trial:** - People who are on hemodialysis and have been diagnosed with overactive parathyroid glands caused by chronic kidney disease (a condition called secondary hyperparathyroidism), where their treating doctor has planned to give them a medication called Pacitol Injection based on i...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06173323 · University of Alabama at Birmingham Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2028
🇺🇸 US

**Who might be able to join this trial:** **Patients:** - Adults aged 18 or older. - People with a confirmed diagnosis of stage 4 chronic kidney disease, based on specific kidney function test results recorded in their medical records within the past 90 days. - People who are able to speak and read English and complet...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06190717 · Sonavex, Inc. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2027
🇺🇸 US

**Who might be able to join this trial:** - You are a man or a woman (not pregnant or breastfeeding) between 18 and 84 years old at the time of signing the consent form. - You are able and willing to sign a written consent form before any study-specific steps are taken. - You are willing and able to attend all require...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06202235 · Shengjing Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 8 June 2027
🇨🇳 CN

Who might be able to join this trial: - Adults who have been diagnosed with chronic kidney disease (CKD) based on 2024 international kidney health guidelines, shown by either abnormal kidney function blood tests or unusual levels of protein in the urine - People who had a kidney MRI scan performed within 7 days of havi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06203977 · Hamilton Health Sciences Corporation Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 31 May 2026
🇨🇦 CA

**Who might be able to join this trial:** - People who have significantly reduced kidney function (a specific kidney function score of 30 or below, measured on at least two separate occasions at least 2 months apart), do not currently need dialysis, and are not expected by their kidney doctor to need dialysis within t...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06224140 · Assistance Publique Hopitaux De Marseille Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
🇫🇷 FR

Who might be able to join this trial: - Adults aged 18 years or older. - People with end-stage kidney disease who have been receiving intermittent hemodialysis (kidney dialysis) for more than 3 months before the screening visit, with each dialysis session lasting at least 4 hours. - People whose dialysis sessions have...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06224153 · Assistance Publique Hopitaux De Marseille Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 December 2027
🇫🇷 FR

**Who might be able to join this trial:** - You are 18 years of age or older - You are willing and able to understand what the study involves and have agreed to take part - You have been diagnosed with stage 4 or 5 chronic kidney disease (CKD) - You are already part of a specific kidney care pathway called the MRC path...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06225544 · Charite University, Berlin, Germany Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 30 January 2025
🇩🇪 DE

**Who might be able to join this trial:** - You are male or female, aged between 18 and 80 years old. - If you are a woman who could become pregnant, you agree to either avoid sex or use contraception throughout the study. - You are able to understand the study and give written consent to take part after being fully in...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06227468 · Athens LifeTech Park Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2025
🇬🇷 GR

**Who might be able to join this trial:** - People aged 18 or older who have a Greek social security number and are visiting a hospital, clinic, or private laboratory in Greece as part of their regular medical care - People who are willing and able to sign a written consent form agreeing to take part in the study **Wh...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06234410 · University of Edinburgh Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2032
🇬🇧 GB

Who might be able to join this trial: - People who have kidney failure and are currently on the waiting list for a kidney transplant - People who are 16 years of age or older - People who are able to give their own informed consent to take part in the study Who may not be able to join: - People who cannot have a CT sc...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06243731 · Takeda Not Applicable · 7 countries Recruiting
Recruiting Not Applicable Est. completion 31 January 2027
🇧🇪 BE🇪🇪 EE🇫🇷 FR🇩🇪 DE🇮🇹 IT🇪🇸 ES🇬🇧 GB

Who might be able to join this trial: - You must be 18 years of age or older at the time you entered the study. - You must have been diagnosed with either end-stage kidney disease (very advanced kidney failure) or severe chronic kidney disease before entering the study — confirmed by a blood test that measures how well...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06249373 · Suzhou Municipal Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇨🇳 CN

**Who might be able to join this trial:** - People aged between 18 and 75 years old, of any gender or ethnicity - People on dialysis or not yet on dialysis who have recently had a new wrist fistula (a surgically created connection between an artery and vein in the wrist) created but have not yet used it for dialysis t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06256991 · University Medical Center Groningen Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 December 2026
🇳🇱 NL

Who might be able to join this trial: - Adults aged 18 or older. - People with moderate-to-severe chronic kidney disease, specifically a kidney function level (eGFR) between 15 and 44 mL/min/1.73 m². - People who have protein in their urine above certain measured levels (confirm with trial site for exact values). - Peo...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06257134 · Central Hospital, Nancy, France Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 September 2026
🇫🇷 FR

**Who might be able to join this trial:** **For patients:** - Adults aged 18 or older who have been fully informed about the study and have not objected to taking part or to their data being used - People with end-stage kidney disease (kidney failure) who are receiving dialysis at one of the clinics taking part in the...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06272578 · Charite University, Berlin, Germany Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 27 February 2025
🇩🇪 DE

**Who might be able to join this trial:** - People who have chronic kidney disease at stages G1 through G4, with kidney function test results (eGFR) either at or above 60 (if protein levels in urine are also elevated) or between 15 and 60 - People who have been diagnosed with type 2 diabetes, shown through a blood sug...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06274710 · University Health Network, Toronto Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 13 April 2026
🇨🇦 CA

**Who might be able to join this trial:** - Adults aged 18 or older who have been diagnosed with chronic kidney disease (CKD) and have a greater than 10% chance of needing dialysis within 2 years, based on a specific kidney risk calculation tool - People who are registered as patients at a kidney specialist (nephrolog...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06278207 · Bayer Not Applicable · 4 countries Recruiting
Recruiting Not Applicable Est. completion 30 September 2026
🇩🇪 DE🇯🇵 JP🇹🇼 TW🇺🇸 US

**Who might be able to join this trial:** - People who have been continuously receiving medical care from the same healthcare providers (with both medical and pharmacy records) for at least 12 months before the start date. - People who have not been prescribed the medication finerenone at any point in the 12 months be...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06286748 · Universidade Federal Fluminense Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 10 November 2026
🇧🇷 BR

**Who might be able to join this trial:** - People who have chronic kidney disease (CKD) at a moderate to severe stage (stages G3a to G4) and are being managed without dialysis - People aged between 18 and 65 years old - People who have been receiving dietary or nutritional monitoring for more than 6 months **Who may...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06300788 · Centre Hospitalier Universitaire de Nice Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 27 November 2026
🇫🇷 FR

Who might be able to join this trial: - Children and teenagers under 18 years old - Both boys and girls are eligible - Patients and their parents or guardians who have been informed about the trial and have signed a consent form - Patients who are covered by social security (French public health insurance) - For the co...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06306963 · Mayo Clinic Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
🇺🇸 US

Who might be able to join this trial: - You must be older than 18 years of age - You must have been diagnosed with Gastric Antral Vascular Ectasia (a condition affecting blood vessels in the stomach), confirmed by a camera examination of the stomach (endoscopy) - You must be willing to take part in the study - You must...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06314503 · UMC Utrecht Not Applicable · 3 countries Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇮🇹 IT🇳🇱 NL🇪🇸 ES

**Who might be able to join this trial:** - People aged 18 or older - People who have been receiving peritoneal dialysis (a type of kidney treatment that filters waste through the abdomen) for at least 3 months before joining - People whose peritoneal dialysis catheter (the tube used for the treatment) is working well...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06324045 · Hamad Medical Corporation Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
Qatar

Who might be able to join this trial: - People diagnosed with end-stage kidney disease (when the kidneys have nearly or completely stopped working) who are currently receiving dialysis treatment through a machine that filters the blood. - People with advanced kidney disease who are being monitored at a specialist clini...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06325488 · Caroline Michaela Kistorp Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2026
🇩🇰 DK

**Who might be able to join this trial:** *For people with Fabry disease:* - You are 18 years of age or older - You are able to understand and agree to participate in the study (give informed consent) *For people in the control group (without Fabry disease):* - You are 18 years of age or older - You are able to under...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06329310 · Xeltis Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇵🇹 PT🇷🇸 RS

Who might be able to join this trial: - People with kidney failure (end-stage renal disease) who need a type of blood vessel access called an arteriovenous graft (AVG) placed in their arm to start or continue dialysis treatment - People who are at least 18 years old at the time of screening - People whose arm anatomy i...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06337838 · Hamilton Health Sciences Corporation Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 February 2027
🇨🇦 CA

Who might be able to join this trial: - People who either have significantly reduced kidney function (based on a blood test result from the past 6 months), or have received dialysis (any type) within the last 7 days - People who are scheduled to have non-heart surgery — whether planned in advance, urgent, or emergency...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06341452 · Fresenius Medical Care Deutschland GmbH Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇨🇿 CZ

Who might be able to join this trial: - People who are at least 18 years old and able to understand and consent to taking part in the trial - People who have been diagnosed with end-stage kidney disease (the most advanced stage of chronic kidney disease, where the kidneys are functioning at 15 ml/min or less) - People...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06343727 · Seven Oaks Hospital Chronic Disease Innovation Centre Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 11 August 2026
🇨🇦 CA

**Who might be able to join this trial:** - You are willing and able to give your consent to take part in the trial - You are male or female, aged 18 or older, and have chronic kidney disease (CKD) - You have been receiving regular in-center hemodialysis (kidney dialysis at a clinic) for more than 3 months - Your blood...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06356168 · University of Pennsylvania Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2026
🇺🇸 US

Who might be able to join this trial: - People who have been diagnosed with end-stage kidney disease and have been receiving hemodialysis (a machine-based blood-cleaning treatment) three times per week for at least one month. Who may not be able to join: - People who are currently acutely ill (suddenly or severely unw...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06364358 · University of Chicago Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2025
🇺🇸 US

Who might be able to join this trial: - People who identify as African American - Adults between the ages of 18 and 70 - People whose kidneys are working at a reduced level, specifically with a kidney function score (called eGFR) below 45, due to a long-term kidney condition - People who are already enrolled in a progr...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06366230 · University of California, San Francisco Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 30 June 2028
🇺🇸 US

Who might be able to join this trial: - Adults who have a blood urea (waste product) level higher than 120 - Adults who have a high potassium level in their blood (above 5.5), or a low bicarbonate level in their blood (below 15), or who need urgent dialysis because they have swallowed a toxic substance - Adults who nee...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06366529 · Zhen Li Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2030
🇨🇳 CN

Who might be able to join this trial: - People who have suspected or confirmed kidney problems and have been prescribed an MRI scan - People of any age or gender - People who are willing to take part in the trial and have signed a written consent form Who may not be able to join: - People who have a pacemaker made of...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06374537 · University of Illinois at Chicago Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 22 May 2026
🇺🇸 US

Who might be able to join this trial: - People who are seriously unwell due to kidney disease and are currently on dialysis, have stage 4 chronic kidney disease (meaning the kidneys are working at 15–29% of normal function), have stage 5 chronic kidney disease (meaning the kidneys are working at less than 15% of normal...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06383208 · China-Japan Friendship Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2027
🇨🇳 CN

Who might be able to join this trial: - People aged between 18 and 80 years old - People who have been diagnosed with coronary heart disease during a hospital stay through a procedure that looks at the heart's arteries (coronary angiography), including heart attacks with a specific pattern on a heart tracing (STEMI), o...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06402851 · Hospital Sirio-Libanes Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 December 2026
🇧🇷 BR

**Who might be able to join this trial:** - You have been diagnosed with atrial fibrillation or atrial flutter (any type — occasional, recurring, or continuous) - Your doctor has calculated a stroke risk score (called CHA2DS2-VASc) of 2 or more points (or 3 or more points if you are female) - You have advanced chronic...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06410144 · University of Rochester Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2028
🇺🇸 US

**Who might be able to join this trial:** - You are 75 years old or older - Your kidneys are working at less than 30% of their normal function (advanced kidney disease) - You speak English - You have not yet made a decision about whether to have dialysis (a treatment that does the work of the kidneys) **Who may not be...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06411353 · Mario Negri Institute for Pharmacological Research Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2028
🇮🇹 IT

Who might be able to join this trial: - People aged between 18 and 90 years, of any gender, who are able to give their consent to participate before any study procedures begin. - People who are already on haemodialysis (a treatment that filters the blood using a machine) and need a new way to access their blood vessels...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06422871 · Merit Medical Systems, Inc. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 June 2027
🇺🇸 US

Who might be able to join this trial: - You must be willing and able to sign a consent form agreeing to take part in the study. - You must be 18 years old or older. - You must have end-stage kidney disease and be receiving hemodialysis (a treatment that filters your blood using a machine). - You must be receiving treat...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06430684 · Ann & Robert H Lurie Children's Hospital of Chicago Early Phase 1 · 1 country Recruiting
Recruiting Early Phase 1 Est. completion 1 June 2026
🇺🇸 US

**Who might be able to join this trial:** - People who have stage 3 or 4 chronic kidney disease (CKD), with kidney function test results falling within a specific range (confirm with trial site for exact values) **Who may not be able to join:** - People who have heart disease - People who have diabetes - People who ar...

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.
NCT06438445 · Universidade Federal Fluminense Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 22 December 2026
🇧🇷 BR

Who might be able to join this trial: - People who have chronic kidney disease (CKD) and have been receiving hemodialysis (a treatment that filters the blood using a machine) for more than 6 months - People who have a type of surgically created blood vessel connection in their arm, called an arteriovenous fistula (AVF)...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06439862 · Hospices Civils de Lyon Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2026
🇫🇷 FR

Who might be able to join this trial: - The patient must be male and have a parent or relative involved - The patient must be between 6 and 17 years old - The patient must have been treated for a urinary condition called posterior urethral valves (PUV) during their first year of life, between 2006 and 2018 - The patien...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06458322 · Ciusss de L'Est de l'Île de Montréal Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇨🇦 CA

Who might be able to join this trial: - Adults who are being seen at a clinic for advanced chronic kidney disease - People whose kidneys are functioning at a very low level (a measure called eGFR at or below 12 mL/min/1.73m²) (confirm with trial site) - People who can communicate in English or French Who may not be ab...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06463483 · Imperial College London Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2026
🇬🇧 GB

Who might be able to join this trial: - People aged between 18 and 70 years old (inclusive) - People who have had Type 1 diabetes for at least one year, or people with Type 2 diabetes who manage their blood sugar using multiple daily insulin injections or an insulin pump - People whose HbA1c (a measure of average blood...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06466785 · Genexine, Inc. Phase 3 · 11 countries Recruiting
Recruiting Phase 3 Est. completion 1 June 2027
Armenia🇧🇬 BG🇨🇿 CZ🇬🇪 GE🇮🇩 ID🇮🇹 IT🇵🇱 PL🇷🇸 RS +3 more

**Who might be able to join this trial:** - Adults aged 18 or older - People who have given their written, voluntary agreement to take part after being fully informed about the study and having the chance to ask questions - People with advanced (stage 5) chronic kidney disease, with a kidney function measurement (eGFR...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06474169 · Centre Hospitalier Régional d'Orléans Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇫🇷 FR

Who might be able to join this trial: - People aged 18 or older, of any gender - People who have been informed about the study and do not object to taking part Who may not be able to join: - People who have a long-term, ongoing infection that is getting worse over time - People who have previously had an organ transpl...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06487546 · Stanford University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2029
🇺🇸 US

"Who might be able to join this trial: - People who have kidney failure and are currently receiving hemodialysis or peritoneal dialysis (two types of kidney replacement treatment) Who may not be able to join: - People who have had a blood transfusion in the last 90 days - People who are currently taking any supplement...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06495177 · European Society of Cardiology Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2025
Turkey (Türkiye)

Who might be able to join this trial: - You must be at least 18 years old at the time you are identified for the study - You must have signed a consent form agreeing to take part - Between 6 and 24 months must have passed since your qualifying health event or diagnosis - You may qualify if you have had a heart-related...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06501222 · Yuanjun Yang Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 March 2026
🇨🇳 CN

**Who might be able to join this trial:** - People who have chronic kidney disease (CKD) with kidney function at or above a certain level (an eGFR of 15 ml/min/1.73m² or higher) - People who are 18 years of age or older - People whose kidneys are leaking only a moderate amount of protein into their urine (no more than...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06516653 · Laminate Medical Technologies Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2027
🇺🇸 US

**Who might be able to join this trial:** - People who are scheduled to have a new surgical connection made between an artery and vein in the wrist or upper arm area (called an AV fistula) for kidney dialysis, and who agree to take part in the study. - Men and women who are not pregnant. - People between 18 and 80 year...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06521801 · Queen Mary University of London Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2030
🇬🇧 GB

**Who might be able to join this trial:** - People aged 16 years or older, both male and female, may be included. - People who have been seen by the Kidney (Nephrology) team at the Royal Liverpool Hospital for a kidney-related condition may be included. - Adults who are considered vulnerable or unable to give consent m...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06527768 · Chinese University of Hong Kong Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 July 2026
🇨🇳 CN

**Who might be able to join this trial:** - People aged 18 years or older - People who have been diagnosed with both Metabolic Syndrome (a combination of conditions including a large waist size, high blood fats, low "good" cholesterol, high blood sugar, and high blood pressure) and Chronic Kidney Disease (CKD) - People...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06533254 · Scaled Insights Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2025
🇺🇸 US

Who might be able to join this trial: - People who are 18 years of age or older - People who have been diagnosed with Chronic Kidney Disease at stage 4 or 5 (the more advanced stages of kidney disease) - People who currently live in the United States or the United Kingdom Who may not be able to join: - People who are...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06551311 · National Cheng Kung University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2026
🇹🇼 TW

Who might be able to join this trial: - People who have been diagnosed with chronic kidney disease (CKD) - People whose kidneys are functioning at a reduced level (as measured by a specific kidney function test), or who are already on regular dialysis - People who are able to communicate, understand instructions, and f...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06552169 · Singulera Therapeutics Inc. Phase 2 · 2 countries Recruiting
Recruiting Phase 2 Est. completion 1 December 2027
🇹🇼 TW🇺🇸 US

**Who might be able to join this trial:** - Adults between 18 and 65 years old who are planning to receive a single kidney transplant from a living donor. - The living kidney donor must also be between 18 and 65 years old. A close tissue match between donor and recipient is not required. - The donor and recipient must...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06556407 · University of Erlangen-Nürnberg Medical School Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇩🇪 DE

Who might be able to join this trial: - People who have high blood pressure that remains uncontrolled despite taking three different types of blood pressure medications, confirmed by a 24-hour blood pressure monitoring test showing readings above the thresholds set by current guidelines. - People who have end-stage kid...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06567938 · First Affiliated Hospital Xi'an Jiaotong University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
🇨🇳 CN

**Who might be able to join this trial:** - People who have chronic kidney disease with a reduced kidney filtering rate (eGFR below 60 mL/min/1.73 m²) - People who have a new blockage in a coronary artery that is suitable for treatment with a specific type of metal heart stent, and where a special imaging technique cal...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06571344 · Medical University of Gdansk Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇵🇱 PL

Who might be able to join this trial: - People with advanced chronic kidney disease (stage 5) who are on dialysis and have low vitamin D levels (a blood test result showing 25(OH)D below 30 ng/mL) Who may not be able to join: - People who have been on dialysis for less than 3 months - People whose parathyroid gland ov...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06572215 · King's College Hospital NHS Trust Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇬🇧 GB

Who might be able to join this trial: - You have sickle cell disease that has affected your kidneys (either confirmed by a doctor's assessment or a kidney biopsy), with a specific type of sickle cell disease called Hb SS and kidney function測 measured at 135 ml/min/1.73m² or above (confirm with trial site) - You have pr...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06576479 · NIN Institute Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2025
🇲🇽 MX

**Who might be able to join this trial:** - People who are 18 years of age or older - People who have diabetic kidney disease with reduced kidney function at a specific level (known as stage G3a, G3b, or G4 — confirm exact level with trial site) - People whose blood protein levels (albumin) are below a certain threshol...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06577805 · West China Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2024
🇨🇳 CN

Who might be able to join this trial: - People who have received a kidney transplant from a living donor - People who are currently on the standard three-drug anti-rejection medication regimen Who may not be able to join: - People who currently have an active infection - People who have received more than one organ as...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06578533 · Fundación para la Investigación del Hospital Clínico de Valencia Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 30 July 2025
🇪🇸 ES

**Who might be able to join this trial:** - People whose blood potassium level was between 5.5 and 6.5 mEq/L at their first screening visit, and between 5.0 and 6.5 mEq/L at the follow-up visit when treatment is assigned. - People who have given their written agreement (or whose legal representative has done so) to ta...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06591702 · Hacettepe University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 21 February 2026
Turkey (Türkiye)

Who might be able to join this trial: - People who have been diagnosed with chronic kidney disease, OR are currently receiving dialysis treatment, OR have had a kidney transplant - People who are over 18 years old - People who have given their consent to take part in the trial Who may not be able to join: - People who...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06598436 · University of California, San Francisco Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2028
🇺🇸 US

**Who might be able to join this trial:** - People who are 18 years of age or older - People who speak English or Spanish - People who have been diagnosed with diabetes and have had a blood sugar control test (called an A1C) result of 8.0% or higher in the past two years, OR people who have been diagnosed with high blo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06607913 · VA Office of Research and Development Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2028
🇺🇸 US

Who might be able to join this trial: - People who are older than 55 years of age - People who have been diagnosed with stage 3 or 4 chronic kidney disease, or whose kidney function test (eGFR) shows a result below 45 mL/min/1.73m² Who may not be able to join: - People whose blood pressure is poorly controlled and con...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06613568 · Diality Inc. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2027
🇺🇸 US

**Who might be able to join this trial:** - People aged between 18 and 80 years old, whose Care Partner is also at least 18 years old at the time of signing consent - People who have been diagnosed with end-stage kidney disease (kidney failure) and are being treated with regular dialysis, with their dialysis working we...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06618859 · de Seigneux Sophie Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2027
🇨🇭 CH

**Who might be able to join this trial:** - Adults (men and women) - People who have been diagnosed with Chronic Kidney Disease at a moderate stage, specifically with a kidney filtration rate between 30 and 90 mL/min/1.73m² (known as KDIGO stage G2 or G3) - People who have a moderate-to-high level of protein (albumin)...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06631820 · Karolinska Institutet Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2026
🇸🇪 SE

**Who might be able to join this trial:** - Your kidneys are working at a low level (a kidney function score below 29 out of a possible 100+), as measured by a standard blood test - You do not have any known liver disease, whether long-term or recent - Your kidney specialist does not expect you to need dialysis or anot...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06635525 · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2026
🇮🇹 IT

Who might be able to join this trial: - People aged between 18 and 70 years old - People who have been receiving kidney dialysis (either hemodialysis three times per week, or peritoneal dialysis) for at least 3 months, OR healthy people with no history of kidney problems - People for whom a seasonal flu vaccine would b...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06635590 · Saglik Bilimleri Universitesi Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2025
Turkey (Türkiye)

Who might be able to join this trial: - You must be 18 years of age or older - You have been diagnosed with chronic kidney disease where your kidneys are working at a reduced level (specifically, an eGFR below 60 mL/min/1.73 m²) (confirm with trial site if unsure about your eGFR level) - You were found to have high pot...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06660277 · London Health Sciences Centre Research Institute OR Lawson Research In... Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2030
🇨🇦 CA

Who might be able to join this trial: - People who are 60 years of age or older, OR people aged 45 to 59 years who have been diagnosed with diabetes (either Type 1 or Type 2), regardless of how their blood sugar is currently managed - People who have been regularly receiving some form of dialysis for at least the past...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06660524 · China National Center for Cardiovascular Diseases Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 June 2025
🇨🇳 CN

Who might be able to join this trial: - People who are 50 years of age or older. - People who have been clearly diagnosed with degenerative (age-related wear and tear) heart valve disease, confirmed by ultrasound or medical history, with signs of calcium buildup in the valve — this includes cases ranging from no valve...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06671535 · Saint Petersburg State University, Russia Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2025
🇷🇺 RU

**Who might be able to join this trial:** - You have been diagnosed with advanced (stage 5) chronic kidney disease and have been receiving regular hemodialysis (kidney dialysis) for at least 3 months before the screening visit. - You experience moderate to severe itching, meaning your itching scores 4 or higher on a st...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06674031 · Hacettepe University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2025
Turkey (Türkiye)

Who might be able to join this trial: - People who have been diagnosed with chronic kidney disease (a long-term condition where the kidneys do not work as well as they should) - People who are between 18 and 65 years old - People who are willing to take part in the study on their own accord Who may not be able to join...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06676696 · Hospital Universitari Vall d'Hebron Research Institute Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 31 January 2028
🇪🇸 ES

**Who might be able to join this trial:** - People who are able to understand the study and sign a written consent form - People aged 18 or older who have had at least one previous kidney transplant - People whose transplanted kidney has stopped working (for any reason), but lasted at least 3 months before failing - Pe...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06677437 · Hospices Civils de Lyon Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2024
🇫🇷 FR

Who might be able to join this trial: - You are between 18 and 85 years old (being older than 85 may still be considered in rare cases — confirm with trial site) - You have long-term kidney failure (your kidneys are no longer working well enough on their own) - You are currently on the waiting list for a kidney transpl...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06683339 · Hacettepe University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2024
Turkey (Türkiye)

Who might be able to join this trial: - People who have been diagnosed with chronic kidney disease - People who are in a stable condition (not experiencing acute illness or significant changes in health) - People who are between 6 and 18 years old - People who are willing to voluntarily take part in the research Who m...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06693661 · Emory University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2028
🇺🇸 US

**Who might be able to join this trial:** - People who identify as African American or Black - People who have had two kidney function test results (called eGFR) below 29, taken at least 90 days apart but within the past 2 years — OR — people whose kidney failure risk score shows a 10% or greater chance of kidney failu...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06696274 · Kirsehir Ahi Evran Universitesi Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2025
Turkey (Türkiye)

**Who might be able to join this trial:** - People who have end-stage kidney disease and are receiving hemodialysis (a treatment that filters the blood using a machine) - People who have been receiving hemodialysis for more than 3 months - People who are considered medically stable - People who are willing to take part...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06701825 · Instituto de Investigación Hospital Universitario La Paz Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 October 2026
🇪🇸 ES

**Who might be able to join this trial:** - People who are willing and able to give written consent before any study procedures begin. - People whose legally authorised representative has signed the consent form, if the person cannot sign themselves. - People who are currently on a waiting list for a kidney transplant....

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06707532 · 4th Military Clinical Hospital with Polyclinic, Poland Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇵🇱 PL

Who might be able to join this trial: - You need to be scheduled to have a specific type of heart procedure called pulsed field ablation (PFA) for a heart-related condition - You must be willing and able to agree to take part in the study by signing a consent form Who may not be able to join: - You have a known allerg...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06712407 · Calliditas Therapeutics AB Phase 4 · 2 countries Recruiting
Recruiting Phase 4 Est. completion 29 May 2026
Puerto Rico🇺🇸 US

**Who might be able to join this trial:** - People who have been diagnosed with IgA nephropathy (a kidney condition), confirmed by a kidney biopsy - Adults aged 18 or older, of any gender - People who have already completed one full 9-month course of commercial TARPEYO® 16 mg (taken once daily), with that completion r...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06712654 · R1 Therapeutics Phase 2 · 2 countries Recruiting
Recruiting Phase 2 Est. completion 28 February 2027
🇨🇳 CN🇺🇸 US

**Who might be able to join this trial:** - People who are willing to sign a consent form and follow all study requirements - People who have been receiving hemodialysis (including hemodialysis, hemodiafiltration, or hemoadsorption) three times per week for at least 12 weeks, with no plans to change this during the st...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06721143 · AION Healthspan, Inc. Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 January 2027
🇺🇸 US

**Who might be able to join this trial:** - People who are able to communicate clearly with the research team, understand the study requirements, and are willing to sign a consent form before any study procedures begin. - People who are willing and able to attend scheduled visits and follow the treatment plan. - Peopl...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06725810 · Shanghai Zhongshan Hospital Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 January 2029
🇨🇳 CN

**Who might be able to join this trial:** - You are between 18 and 75 years old at the time of signing up - Your body weight is between 45 and 100 kg (approximately 99–220 lbs) - You have been diagnosed with chronic kidney disease (CKD) at a moderate-to-severe stage, but you are not currently on dialysis - You have be...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06732349 · Erasmus Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2029
🇳🇱 NL

Who might be able to join this trial: - People who have moderate chronic kidney disease, meaning their kidneys are working at a reduced level (a lab measure called eGFR falls between 30 and 59 ml/min, which doctors classify as stage 3) Who may not be able to join: - People who have an active kidney inflammation condit...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06738394 · Wake Forest University Health Sciences Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2026
🇺🇸 US

**Who might be able to join this trial:** - People who have been diagnosed with chronic kidney disease at stage 3, 4, or 5 - People who are physically able to do exercise - People who live within 20 miles of the Wake Forest Reynolda Campus - People who speak and understand English fluently - People who do not plan to t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06749457 · AstraZeneca Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 2 April 2027
🇺🇸 US

**Who might be able to join this trial:** **Phase I (healthy volunteers):** - Adults between 18 and 55 years old at the time of signing the consent form. - People with a body weight between 45 kg and 110 kg, and a BMI between 18.0 and 30.0. - People who are generally healthy, with no significant ongoing illnesses or r...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06750575 · UMC Utrecht Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2025
🇳🇱 NL

**Who might be able to join this trial:** - People who are 18 years of age or older - People who have been diagnosed with chronic kidney disease (stage 3–5), meaning their kidneys have been functioning at a reduced level for at least three months - People for whom a doctor has decided, as part of their normal care, tha...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06752577 · Mayo Clinic Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2030
🇺🇸 US

Who might be able to join this trial: - People who are over 18 years of age - People whose kidneys are working at a reduced level (a kidney function score below 60 mL/min/1.73m²) - People with diabetes whose blood sugar control meets a specific threshold (a blood test called HbA1c showing 9% or below) - People who have...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06754280 · University of Illinois at Chicago Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
🇺🇸 US

**Who might be able to join this trial:** - People who identify as Black or African American - People between the ages of 35 and 80 years old - People who have been diagnosed with chronic kidney disease (CKD) at stage 1, 2, 3, or 4 - People who report spending 6 or more hours per day sitting or being inactive - People...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06794216 · IRCCS Azienda Ospedaliero-Universitaria di Bologna Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2025
🇮🇹 IT

Who might be able to join this trial: - People who are 18 years of age or older - People who have been receiving regular kidney dialysis (hemodialysis) for at least 6 months, using one of several specific types of dialysis filters or methods (confirm with trial site for which specific filter or method applies) - People...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06794593 · Odense University Hospital Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 31 December 2025
🇩🇰 DK

**For Patients with Chronic Kidney Disease (CKD):** Who might be able to join this trial: - People aged 18 or older - People who have been diagnosed with chronic kidney disease (CKD) of any cause, with kidney function and protein-in-urine levels within specific ranges at screening (confirm with trial site) - People wh...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06799936 · The University of Hong Kong Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 April 2027
Hong Kong

**Who might be able to join this trial:** *For doctors/clinicians:* - You are a kidney specialist (nephrologist) or a senior doctor in training who provides specialist care to older adults with serious kidney disease *For patients:* - You have been diagnosed with advanced chronic kidney disease (stage 4 or 5), meanin...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06801262 · IRCCS Azienda Ospedaliero-Universitaria di Bologna Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2026
🇮🇹 IT

Who might be able to join this trial: - **Group A (Healthy donors):** Adults who donate blood through the Metropolitan Immunohematology and Transfusion Medicine Service — blood samples from this group are used anonymously, so no separate consent is needed from these donors. - **Group B (Kidney transplant patients):**...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06802978 · Sohag University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 January 2026
🇪🇬 EG

Who might be able to join this trial: - People who have been diagnosed with chronic kidney disease (a long-term condition where the kidneys do not work as well as they should) and are attending Sohag University Hospital. - People who are older than 20 years of age. - People who have given their consent to take part in...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06810258 · Assistance Publique - Hôpitaux de Paris Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 8 October 2034
🇫🇷 FR

Who might be able to join this trial: - People who are in hospital for a kidney biopsy (where a small sample of kidney tissue is taken) on their own natural kidney, or for a kidney transplant - People who are over 18 years old - People who have been fully informed about the trial and have given their written agreement...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06830629 · Maze Therapeutics Phase 2 · 3 countries Recruiting
Recruiting Phase 2 Est. completion 1 September 2026
🇫🇷 FR🇬🇧 GB🇺🇸 US

Who might be able to join this trial: - You carry a specific genetic variation called APOL1 high risk genotype (either G1/G1, G2/G2, or G1/G2) — this is determined by a genetic test - You have chronic kidney disease with a lasting higher-than-normal level of protein in your urine (confirm with trial site) Who may not...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06836206 · Abu Dhabi Health Services Company Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 30 November 2025
🇦🇪 AE

**Who might be able to join this trial:** - Adults aged 18 or older who have been diagnosed with end-stage kidney failure and have been receiving dialysis at least once a week for the past two weeks. - Women who are able to become pregnant but are using a form of contraception, have decided not to have more children,...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06837766 · IRCCS Azienda Ospedaliero-Universitaria di Bologna Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 February 2025
🇮🇹 IT

**Who might be able to join this trial:** - People who have been diagnosed with a sudden, severe worsening of a long-term liver condition, where at least two major organs are failing at the same time (a condition graded as ACLF grade 2 or higher, confirmed using a specific medical scoring system) - People who are rece...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06841692 · Erasmus Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 October 2029
🇳🇱 NL

**Who might be able to join this trial:** - People with chronic kidney disease at stage G3, meaning their kidney filtration rate (a measure of how well the kidneys clean the blood) was between 30 and 59 units at their last clinic visit - Healthy people whose kidney filtration rate is within the normal expected range f...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06843902 · Massachusetts General Hospital Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 March 2029
🇺🇸 US

**Who might be able to join this trial:** - You were born female - You are living with HIV and have been on a stable HIV treatment regimen for at least 180 days (about 6 months) - You are between 45 and 75 years old - You have at least one of the following: type 2 diabetes, reduced kidney filtering function (confirm wi...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06845605 · East and North Hertfordshire NHS Trust Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 January 2025
🇬🇧 GB

Who might be able to join this trial: - People who work as registered nurses or Band 3 healthcare assistants (a support worker role) and carry out needling procedures in a haemodialysis (kidney dialysis) unit. - People who are employed at the kidney dialysis units run by East and North Hertfordshire NHS Trust (ENHT), i...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06847139 · Chittagong Medical College Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 July 2025
Bangladesh

**Who might be able to join this trial:** - People aged 18 years or older - People who have chronic kidney disease and have been receiving haemodialysis (a machine-based kidney treatment) for at least 3 months - People whose blood test shows a homocysteine level above 15 µmol/L (homocysteine is a naturally occurring su...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06858280 · Mario Negri Institute for Pharmacological Research Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 July 2026
🇮🇹 IT

**Who might be able to join this trial:** - People who are over 18 years old - People who have been on stable dialysis three times per week for at least three months due to permanent kidney failure - People whose blood potassium level (measured before dialysis, after the longest break between sessions) is between 4.0...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06860711 · University of Colorado, Denver Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 June 2028
🇺🇸 US

Who might be able to join this trial: - You are older than 18 months of age - You have been diagnosed with a moderate level of chronic kidney disease (specifically stages 2 to 3a), confirmed by a specific kidney function blood test done within the last 6 months - You are already scheduled to have a urological (urinary...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06861816 · Cairo University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2025
🇪🇬 EG

Who might be able to join this trial: - Adolescents (40 participants total) who have end-stage kidney disease (when the kidneys have stopped working properly) - People who are already receiving regular hemodialysis (a treatment that filters waste from the blood using a machine) Who may not be able to join: - People wh...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06862466 · Universiti Putra Malaysia Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2025
🇲🇾 MY

Who might be able to join this trial: - Dietitians who have worked with chronic kidney disease patients - Dietitians who are registered with the Saudi Commission for Health Specialties - Dietitians who have completed at least one year of work experience in their role - Dietitians who agree to take part in the study - D...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06863194 · Mansoura University Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 3 October 2025
🇪🇬 EG

**Who might be able to join this trial:** - Adults aged 18 or older, of any gender - People who have been diagnosed with Chronic Kidney Disease (CKD) at Stage 3 or Stage 4, confirmed by a specific kidney function test called eGFR - People whose condition is currently stable, with no recent hospital stays for sudden kid...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06867471 · Gødstrup Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
🇩🇰 DK

**Who might be able to join this trial:** **Study A (for people with chronic kidney disease, or CKD):** - People whose urine shows a protein level (albumin-to-creatinine ratio) in a specific mid-range — not too low and not too high (confirm with trial site for exact values) - People whose kidneys are still functioning...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06868888 · Chang Gung Memorial Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 20 March 2025
🇹🇼 TW

Who might be able to join this trial: - People who have been receiving hemodialysis and taking related medication for at least 6 weeks - People whose Kt/V score is greater than 1.2 (this is a measurement used to check how well hemodialysis is working — confirm with trial site) Who may not be able to join: - People who...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06873880 · University of Tartu Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2025
🇪🇪 EE

**Who might be able to join this trial:** - People who have been diagnosed with chronic kidney disease - People who have been receiving hemodialysis (a machine-based kidney treatment) for at least 6 months **Who may not be able to join:** - People who are currently pregnant - People who are currently breastfeeding - P...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06877169 · Cedars-Sinai Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 February 2027
🇺🇸 US

Who might be able to join this trial: - Adults aged 18 or older who are receiving both a heart transplant and a kidney transplant at Cedars-Sinai Medical Center. Who may not be able to join: - People who receive both the heart and kidney transplants at the exact same time in a single surgery due to urgent medical need...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06878560 · United Therapeutics Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 October 2028
🇺🇸 US

**Who might be able to join this trial:** - People who are willing to give informed consent to take part in the study and agree to be followed up for the rest of their life - People who have been diagnosed with end-stage renal disease (kidney failure requiring ongoing treatment) - People who have been on dialysis thro...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06886256 · The Methodist Hospital Research Institute Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2025
🇺🇸 US

Who might be able to join this trial: - Adults who are considered frail and are being assessed as a possible kidney transplant recipient at Houston Methodist Hospital - People aged 55 years or older, of any gender - People who are willing and able to sign a dated consent form agreeing to take part in the study - People...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06898294 · The University of Hong Kong Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2025
Hong Kong

**Who might be able to join this trial:** - People who have been clinically diagnosed with chronic kidney disease (CKD) at any stage (stage 1 through 5), based on kidney function test results - People between 18 and 90 years of age, of any gender **Who may not be able to join:** - People in the control group (comparis...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06903559 · Mansoura University Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 15 October 2025
🇪🇬 EG

Who might be able to join this trial: - Adults over 18 years of age. - People who are willing to sign a consent form agreeing to take part in the study. - People who have end-stage kidney disease and have been receiving regular hemodialysis (a machine-based kidney treatment) for more than 3 months. Who may not be able...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06907667 · Centre Hospitalier Universitaire de Nice Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2027
🇫🇷 FR

Who might be able to join this trial: - You have advanced kidney disease (stage 4 or 5), are on dialysis, or have had a kidney transplant - You are 18 years old or older - Your doctor has recommended that you receive a flu vaccine - You are able and willing to give your free and informed consent to participate Who may...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06913647 · McGill University Health Centre/Research Institute of the McGill Unive... Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 28 February 2028
🇨🇦 CA

**Who might be able to join this trial:** - You are an adult with kidney failure who is treated with peritoneal dialysis (a type of home dialysis that uses fluid in the abdomen) and have been on a stable dialysis prescription using sugar-based dialysis fluid for at least 3 months. - Your kidneys have been tested and sh...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06917950 · Mansoura University Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 15 October 2025
🇪🇬 EG

Who might be able to join this trial: - You are over 18 years old. - You are willing to sign a consent form agreeing to take part in the study. - You have end-stage kidney disease and have been receiving regular dialysis (a machine that cleans your blood) for more than 3 months. Who may not be able to join: - You are...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06923709 · Odense University Hospital Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 August 2025
🇩🇰 DK

**Who might be able to join this trial:** - People who are 18 years of age or older at the time of signing the consent form. - People who have been diagnosed with chronic kidney disease, with kidney function test results showing an eGFR between 25 and 60 (a measure of how well the kidneys filter blood), and a urine pr...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06925217 · Heba Al-Alwan Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2027
🇨🇭 CH

**Who might be able to join this trial:** - People who have signed an informed consent form agreeing to take part - People aged 18 years or older - People who have been diagnosed with type 2 diabetes for at least 12 months - People who have been using insulin therapy for at least 6 months - People with chronic kidney...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06927024 · NYU Langone Health Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 January 2029
🇺🇸 US

**Who might be able to join this trial:** - Adults aged 18 or older - People who have been diagnosed with Chronic Kidney Disease (CKD) at a moderate to severe stage (stage 3–5), meaning the kidneys are not filtering blood as well as they should - People who are currently receiving kidney care at the NYU Nephrology outp...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06932042 · Lebanese American University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2026
🇱🇧 LB

Who might be able to join this trial: - Adults aged 18 or older who have been diagnosed with moderate to severe chronic kidney disease (stages 3–5), with kidney function measurements that have been stable for at least three months - People whose blood sugar and blood pressure levels are being managed and kept within a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06935786 · Turku University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2031
🇫🇮 FI

Who might be able to join this trial: - People who are older than 40 years of age - People with severely reduced kidney function, at a level doctors refer to as chronic kidney disease stage 4 or 5 (confirm with trial site) - People who have given their written agreement to take part in the trial Who may not be able to...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06940414 · Xiujuan Zang Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 July 2025
🇨🇳 CN

**Who might be able to join this trial:** - Adults aged 18 or older whose vital signs are stable, meaning body temperature between 36.0°C and 38.0°C, pulse between 50 and 120 beats per minute, breathing rate between 10 and 24 breaths per minute, and blood pressure of at least 90/60 mmHg. - People who are willing to tak...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06971874 · Nanfang Hospital, Southern Medical University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2029
🇨🇳 CN

**Who might be able to join this trial:** - You are willing to voluntarily sign a consent form to take part in the study. - You are aged 18 years or older but under 75 years old. - You have been diagnosed with moderate-to-moderately-severe chronic kidney disease (stages 3–4), meaning your kidneys are working at a reduc...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06976177 · Shaanxi Micot Pharmaceutical Technology Co., Ltd. Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 19 August 2025
🇨🇳 CN

Who might be able to join this trial: - People who are able to understand written information and are willing to sign a written consent form to participate - People who are at least 18 years old at the time of signing the consent form - People who have been receiving hemodialysis (kidney dialysis) either three times pe...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06982079 · Ain Shams University Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 June 2026
🇪🇬 EG

Who might be able to join this trial: - Adults aged 18 or older. - People with advanced chronic kidney disease (a kidney function level below a certain threshold, measured by a blood test) who are not currently on dialysis. Who may not be able to join: - People diagnosed with a genetic kidney condition called autosoma...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06982573 · Bundang CHA Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 19 February 2026
🇰🇷 KR

**Who might be able to join this trial:** - Adults aged 19 years or older - People who have been diagnosed with end-stage kidney failure and are receiving dialysis more than three times per week - People who rate their back pain at 4 or higher out of 10 on a standard pain scale - People whose thinking and memory are cl...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06986265 · Université Catholique de Louvain Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2028
🇧🇪 BE

Who might be able to join this trial: - People who are 18 years of age or older - People who have been diagnosed with kidney failure at the most advanced stage (stage 5) - People who have been on regular dialysis for at least 3 months - People who are able to understand the trial procedures and follow the trial plan W...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06989892 · Navamindradhiraj University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2026
🇹🇭 TH

Who might be able to join this trial: - People who have end-stage kidney disease (where the kidneys have stopped working properly) and who also have a serious blood infection (sepsis), with a specific protein linked to inflammation (interleukin-6) measured above a certain level in their blood Who may not be able to jo...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06997042 · Hospital Clinic of Barcelona Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2027
🇪🇸 ES

**Who might be able to join this trial:** - People aged 18 or older - People who are able to meet the study requirements, including attending follow-up appointments - People who have advanced chronic kidney disease and are already on hemodialysis (kidney dialysis), or who are expected to need hemodialysis within the n...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07007338 · Hospices Civils de Lyon Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2028
🇫🇷 FR

Who might be able to join this trial: - Children between 3 and 17 years of age - Children who are currently receiving ongoing dialysis treatment (hemodialysis, hemodiafiltration, or peritoneal dialysis) - Children whose treating doctor has decided to start them on a medication called cinacalcet, in line with 2019 Europ...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07020104 · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2039
🇳🇱 NL

**Who might be able to join this trial:** - You have chronic kidney disease with kidney function measured at a specific level (eGFR between 15 and 60) — your doctor can confirm this from your blood test results - Your water tablet (diuretic) and blood pressure medication doses have been stable and unchanged for at lea...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07022847 · First Affiliated Hospital of Wannan Medical College Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2025
🇨🇳 CN

Who might be able to join this trial: - Adults between 18 and 80 years of age - People who have been diagnosed with end-stage kidney failure and have been receiving regular dialysis treatment for more than 3 months - People who are willing and able to give their consent to participate and follow the study's procedures...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07025629 · Assistance Publique - Hôpitaux de Paris Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 15 January 2029
🇫🇷 FR

**Who might be able to join this trial:** - Adults aged 18 years or older - People who needed a breathing machine (mechanical ventilator) and/or heart/blood pressure support medications for more than 24 hours during their ICU stay - People whose doctor has decided they are ready to leave the ICU - People who have sign...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07045064 · Cairo University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2026
🇪🇬 EG

Who might be able to join this trial: - People who have been on regular hemodialysis (kidney dialysis) for at least 3 months - People with a body weight that falls within the normal to overweight range (BMI between 18.5 and 29.9 kg/m²) - People aged between 40 and 60 years old - People who attend hemodialysis sessions...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07045467 · Qianfoshan Hospital Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 1 July 2026
🇨🇳 CN

**Who might be able to join this trial:** - People who have provided signed consent to participate - People aged 18 years or older but under 65 years - People with chronic kidney failure who are scheduled to receive a kidney transplant - People with a body mass index (BMI) between 18 and 30 (a standard measure of body...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07047547 · Guangdong Provincial People's Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇨🇳 CN

**Who might be able to join this trial:** - You are between 18 and 80 years old. - You have been diagnosed with chronic kidney disease, meaning your kidneys are not filtering blood at full capacity. - You have chronic heart failure with a weakened heart pump (your heart is pumping at 50% or less of its normal capacity...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07052539 · University of Mississippi Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2026
🇺🇸 US

**Cohort 1: Healthy Participants** Who might be able to join this trial: - Adults between 18 and 75 years old - People with normal kidney function - People without heart failure - People with a body mass index (BMI) between 25 and 30 (considered overweight but not obese) Who may not be able to join: - People with a l...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07054684 · Biohaven Therapeutics Ltd. Phase 1 · 2 countries Recruiting
Recruiting Phase 1 Est. completion 1 July 2027
🇬🇧 GB🇺🇸 US

Who might be able to join this trial: - You have been diagnosed with IgA Nephropathy (a kidney condition), confirmed by a biopsy (a small tissue sample taken from your kidney) Who may not be able to join: - Your IgA Nephropathy is caused by another underlying condition (such as liver disease or another illness), rathe...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07059962 · Bodyport Inc. Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇨🇦 CA🇺🇸 US

Who might be able to join this trial: - People who are 21 years of age or older - People who can speak and read English, or people who can speak and read Spanish and have a caregiver or family member who speaks English and can help them - People who are able to stand on both bare feet without assistance - People who ar...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07088874 · Peking University First Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 July 2026
🇨🇳 CN

Who might be able to join this trial: - People who are 18 years of age or older - People who are scheduled to have surgery to remove one entire kidney Who may not be able to join: - People who only have one kidney - People who have been diagnosed before surgery with advanced chronic kidney disease (specifically stages...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07098351 · Guangdong Provincial People's Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2026
🇨🇳 CN

**Who might be able to join this trial:** - You are between 18 and 85 years old (any gender) - You have chronic kidney failure and have been receiving peritoneal dialysis regularly for at least 3 months, with no major changes to your treatment expected during the trial - You are able to understand the study, follow it...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07105670 · Indiana University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2027
🇺🇸 US

**Who might be able to join this trial:** - People between 40 and 70 years old - Men, or women who have gone through menopause - People who have been diagnosed with Stage 3 chronic kidney disease, meaning their kidneys are working at a reduced level (confirmed by a specific kidney function test result between 30–59 ml/...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07107919 · The Affiliated Hospital of Qingdao University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2026
🇨🇳 CN

Who might be able to join this trial: - You are between 18 and 80 years old (any sex) - You have been diagnosed with chronic kidney disease (CKD) based on recognised medical guidelines - Your medical records and health information are complete and available - You are willing and able to give written permission to take...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07119372 · Biocad Phase 3 · 2 countries Recruiting
Recruiting Phase 3 Est. completion 1 May 2026
Belarus🇷🇺 RU

**Who might be able to join this trial:** - Adults between 18 and 75 years of age at the time of signing the consent form - People with a documented diagnosis of end-stage kidney disease - People who have been receiving dialysis for at least the 90 days before signing the consent form - People on haemodialysis who rec...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07122401 · Shaanxi Micot Pharmaceutical Technology Co., Ltd. Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 26 November 2026
🇨🇳 CN

Who might be able to join this trial: - People who are able to understand written information and are willing to sign a written consent form agreeing to take part - Adults aged 18 or older with a body mass index (a measure of body weight relative to height) between 18 and 35 - People who have been receiving regular dia...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07136792 · Guangdong Provincial People's Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇨🇳 CN

Who might be able to join this trial: - Adults aged between 18 and 75 years, of any gender - People who weigh at least 45 kg and have a body mass index (BMI) of 18.5 or above - People who have been diagnosed with chronic kidney failure and have been on a stable dialysis routine (either peritoneal dialysis or hemodialys...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07144332 · Sohag University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 29 December 2025
🇪🇬 EG

Who might be able to join this trial: - Adults aged 18 or older who have given their consent to participate - People who have been receiving regular hemodialysis (a kidney cleaning treatment) for at least 3 months in a row - People who attend 2 to 3 hemodialysis sessions per week Who may not be able to join: - People...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07146854 · Phraxis, Inc. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2029
🇺🇸 US

Who might be able to join this trial: - People who are 18 years of age or older. - People who have end-stage kidney disease and need a new blood vessel graft created for dialysis. - People whose upper arm is a suitable location for placing the graft. - People (or their legal guardian) who understand the study and are w...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07153432 · Institute for Clinical and Experimental Medicine Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 19 October 2025
🇨🇿 CZ

Who might be able to join this trial: - People over 50 years old, or people over 18 years old who have at least one of the following health conditions: diabetes, high blood pressure, coronary heart disease, stroke, poor circulation in the legs or feet, irregular heartbeat (atrial fibrillation), or heart failure - Peopl...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07153939 · Venova Medical Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
🇺🇸 US

**Who might be able to join this trial:** - People who have kidney failure requiring dialysis through a blood vessel access point, or who have chronic kidney disease and are expected to need dialysis within 6 months - People who have a specific vein in the arm (the cubital perforating vein) measuring between 2.0 and 5...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07157397 · National University of Malaysia Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2027
🇲🇾 MY

**Who might be able to join this trial:** - Adults over 18 years old who attend outpatient clinic visits at HTCM's peritoneal dialysis clinic - People who have been on peritoneal dialysis (a type of kidney treatment done at home through the abdomen) for at least 6 months - People whose blood protein (albumin) level is...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07171216 · Herlev Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2027
🇩🇰 DK

**Who might be able to join this trial:** - You are 50 years of age or older at the time of screening - You have advanced chronic kidney disease (stage 4 or 5) that is not being treated with dialysis, meaning your kidneys are working at less than 30% of normal capacity based on a blood test - Your parathyroid hormone (...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07186218 · Massachusetts General Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2029
🇺🇸 US

Who might be able to join this trial: - People aged 18 or older - People with advanced chronic kidney disease, meaning their kidneys are working at a low level — confirmed by at least two blood tests taken at least 90 days apart within the past 12 months, both showing kidney function at or below a certain threshold - P...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07187713 · Ace Cells Lab Limited Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 31 August 2026
🇪🇬 EG

Who might be able to join this trial: - Adults aged 18 or older who have kidney disease at any stage of severity, including early signs of protein in the urine, more significant protein loss, chronic kidney disease at various stages (not yet requiring dialysis), or kidney disease after a kidney transplant where protein...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT07194590 · University of Colorado, Denver Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 30 November 2030
🇺🇸 US

**Who might be able to join this trial:** - Women who have gone through menopause - People aged 50 years or older - People with moderate-to-severe chronic kidney disease (CKD stage 3 or 4), meaning kidney function is reduced but not at the point of needing dialysis, and kidney function has been stable for the past 3 m...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07203287 · The University of Texas Medical Branch, Galveston Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 31 December 2026
🇺🇸 US

Who might be able to join this trial: - People who are willing and able to give written consent to participate in the trial - People who are between 18 and 80 years of age - People who have chronic kidney disease, defined by a specific measure of how well their kidneys are filtering blood (confirm with trial site for e...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT07206524 · Universitair Ziekenhuis Brussel Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 November 2025
🇧🇪 BE

Who might be able to join this trial: - People who are already participating in the OMAGOD pilot trial Who may not be able to join: - People who are not participating in the OMAGOD pilot trial Important: Always verify eligibility with the trial site directly before applying.

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07211035 · Amplifi Vascular, Inc. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
🇺🇸 US

**Who might be able to join this trial:** - People aged 18 or older - People whose doctor has determined they need a new connection between an artery and vein (called an AVF) created at the wrist or lower forearm for dialysis access - People with end-stage kidney disease who are currently receiving regular hemodialysi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07216885 · Mozarc Medical US LLC Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2026
🇺🇸 US

**Who might be able to join this trial:** - People who are willing and able to give their informed consent to participate - People aged 18 years or older - People who fall into one of these three groups: those who have been on regular, stable haemodialysis (kidney-filtering treatment using a machine) for at least thre...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07217535 · Rutgers, The State University of New Jersey Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 October 2028
🇺🇸 US

Who might be able to join this trial: - People aged 18 years or older - People who are currently living in the United States - People who are able to read and follow written instructions in English - People who have access to the internet and a device such as a computer, laptop, tablet, or smartphone - People who are w...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07222683 · Brigham and Women's Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2030
🇺🇸 US

Who might be able to join this trial: - People who are waiting on a transplant list to receive a kidney - People aged 45 years or older, or people aged 18 to 44 years who have been on dialysis for 5 or more years Who may not be able to join: - People whose heart is pumping at less than 40% of its normal capacity (conf...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07223502 · Sarfez Pharmaceuticals, Inc. Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 July 2026
🇺🇸 US

Who might be able to join this trial: - Adults aged 18 or older, of any gender - People who have been diagnosed with chronic kidney disease (CKD) - People whose kidneys are working at a reduced but not severely low level, based on a specific kidney function test result (eGFR between 25 and 60) - People whose urine sho...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07224763 · United Therapeutics Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 March 2029
🇺🇸 US

**Who might be able to join this trial:** - People who have given their voluntary agreement to take part in the study and to be followed up for the rest of their life - People who have been diagnosed with end-stage renal disease (complete kidney failure) at the time of signing up - People who have been dependent on ki...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07232537 · Bayer Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2027
🇰🇷 KR

Who might be able to join this trial: - Adults of any gender aged 18 or older - People who have been diagnosed by a doctor with chronic kidney disease (CKD) that is linked to type 2 diabetes - People for whom a doctor has decided to prescribe finerenone (10 mg or 20 mg) in line with how it is approved for use in their...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07235059 · Novartis Pharmaceuticals Phase 1 · 2 countries Recruiting
Recruiting Phase 1 Est. completion 21 January 2028
🇩🇪 DE🇺🇸 US

Who might be able to join this trial: - People who are able to give written agreement to participate before any assessments are carried out. - For Part A (healthy volunteers): Men and women who are in good general health, confirmed through medical history, physical check-up, vital signs, heart tracing (ECG), and blood...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07237295 · University of North Carolina, Chapel Hill Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2028
🇺🇸 US

Who might be able to join this trial: - People who have been diagnosed with chronic kidney disease (a long-term condition where the kidneys do not work as well as they should), but not at the most advanced stage (end-stage kidney disease), based on medical records or certain lab results showing reduced kidney function...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07259512 · Evi Liliek Wulandari Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 31 December 2025
🇮🇩 ID

Who might be able to join this trial: - Adults aged 18 years or older, of any sex - People who have been diagnosed with moderate-to-severe chronic kidney disease (stages 3 to 5) that is not being treated with dialysis, and who also have heart failure with a weakened heart pump (where the heart is pumping at less than 4...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT07262333 · Beijing Continent Pharmaceutical Co, Ltd. Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 1 July 2026
🇨🇳 CN

**Who might be able to join this trial:** - People of Chinese background who are either healthy with normal kidney function, or who have been diagnosed with mild, moderate, or severe kidney impairment, based on a specific kidney function measurement (eGFR) taken by a doctor. - People aged 18 to 70 years old (inclusive...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07268638 · Akebia Therapeutics Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 June 2027
🇺🇸 US

**Who might be able to join this trial:** - Your urine protein levels must be at a certain elevated level, measured by a specific urine test called UPCR, showing a result of 1 or higher (confirm with trial site). - You must already be taking the highest dose of a certain type of blood pressure/kidney-protecting medicat...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07269379 · University of Avignon Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 6 May 2028
🇫🇷 FR

**Who might be able to join this trial:** - People aged between 20 and 79 years. - People who have been on hemodialysis (a kidney filtering treatment) for more than 3 months. - People who do not currently take part in regular exercise outside of their dialysis sessions. - People who have not done any exercise during di...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07271186 · Regeneron Pharmaceuticals Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 24 September 2027
🇺🇸 US

Who might be able to join this trial: - People who have been diagnosed with type 2 diabetes and are currently receiving medication or making lifestyle changes to manage their blood sugar levels. - People whose HbA1c (a blood test that shows average blood sugar levels over the past few months) is between 6.5% and 10% at...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07271420 · Chinese University of Hong Kong Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 31 December 2026
Hong Kong

Who might be able to join this trial: - People who are on long-term peritoneal dialysis (a type of kidney treatment done at home using the abdomen) and have high blood pressure that is not well controlled (with readings above certain levels) Who may not be able to join: - People who are not expected to live longer tha...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT07275788 · Regend Therapeutics Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 1 December 2027
🇨🇳 CN

**Who might be able to join this trial:** - People aged between 30 and 75 years old at the time of signing the consent form - People who have been diagnosed with Type 2 Diabetes for at least 1 year - People who have been diagnosed with Chronic Kidney Disease (a long-term condition where the kidneys do not work as well...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07304817 · University Medical Center Groningen Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 February 2028
🇳🇱 NL

**Who might be able to join this trial:** - People aged 18 or older, of any gender, who have signed and dated a consent form before entering the trial - People with heart failure (regardless of how well the heart is pumping) and a certain level of kidney function, as measured by a blood test called eGFR, falling betwe...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07309367 · Duke-NUS Graduate Medical School Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2026
🇸🇬 SG

**Who might be able to join this trial:** **For patients:** - People who are Singapore citizens or permanent residents, aged 21 or older - People who have been diagnosed with the most advanced stage of chronic kidney disease (stage 5) and are currently on dialysis - People who have been identified by National Kidney F...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07330362 · Zhujiang Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇨🇳 CN

Who might be able to join this trial: - You are willing to take part and have signed a consent form agreeing to join the study - You have been diagnosed with, or are suspected of having, chronic kidney disease based on current medical guidelines - You are already having a kidney biopsy done and a tissue sample is being...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07332949 · CMC Ambroise Paré Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 January 2027
🇫🇷 FR

Who might be able to join this trial: - Adults older than 18 years of age. - People who have been on regular dialysis (either hemodialysis or peritoneal dialysis) for at least 6 months. Who may not be able to join: - People living with significant cognitive or psychiatric conditions that would make it difficult to und...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07333313 · National Taiwan University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2029
🇹🇼 TW

**Who might be able to join this trial:** - People over 20 years old who are not pregnant at the time of screening - People who have diabetic kidney disease (a type of kidney damage caused by diabetes) with kidney function and certain blood marker levels that have been stable for at least 30 days - People whose kidney...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07338929 · University Hospital, Martin Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 October 2027
🇸🇰 SK

Who might be able to join this trial: - You must be 18 years old or older and currently being assessed to see if you are a suitable candidate for a kidney transplant. - You must currently be receiving dialysis treatment. - You must be willing and able to agree to take part in the trial. Who may not be able to join: -...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07348237 · Merck Sharp & Dohme LLC Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 20 July 2026
🇺🇸 US

**Who might be able to join this trial:** - People who are generally in good health (those with stable, long-term medical or physical health conditions may still be considered, at the discretion of the trial doctor and study sponsor) - **For the severe kidney impairment group:** People whose kidneys are functioning at...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07350837 · Tongji Hospital Early Phase 1 · 1 country Recruiting
Recruiting Early Phase 1 Est. completion 31 December 2026
🇨🇳 CN

**Who might be able to join this trial:** - Adults between 18 and 65 years old who have end-stage kidney disease (kidneys no longer work), are on a transplant waiting list, and need a special treatment to make a safe kidney transplant possible. - For one group (Cohort 1): A living kidney donor has already been identif...

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.
NCT07358572 · Beijing Friendship Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2031
🇨🇳 CN

Who might be able to join this trial: - People between 18 and 70 years of age - People who have been diagnosed with chronic kidney disease (CKD) at any stage from 1 to 5 - People who are able to safely have an MRI scan, meaning they have no conditions or implanted devices that would make an MRI unsafe (such as a pacema...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07359664 · University of Erlangen-Nürnberg Medical School Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇩🇪 DE

Who might be able to join this trial: **If you have a cardiovascular (heart-related) condition:** - You have been diagnosed with at least one of the following: high blood pressure, type 2 diabetes, chronic kidney disease, or heart failure **If you are a healthy individual:** - Your body weight is in a healthy to slig...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07361146 · Mohammad Arian Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 2 March 2027
Kuwait

**Who might be able to join this trial:** - Adults between the ages of 21 and 65 years old - People who have been diagnosed with end-stage renal disease (kidney failure at its most advanced stage) - People who have been receiving regular kidney dialysis (hemodialysis) for at least 3 months - People whose kidney special...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07374042 · University Hospital, Clermont-Ferrand Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 January 2030
🇫🇷 FR

Who might be able to join this trial: - Adults (men or women) who are over 18 years of age - People who have been diagnosed with stage 4 or 5 chronic kidney disease (CKD), meaning their kidneys are working at a low level, as measured by a specific blood test result below 30 mL/min/m² - People who are not currently on d...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07385651 · Vanderbilt University Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
🇺🇸 US

Who might be able to join this trial: - Adults who are on the waiting list for a single kidney transplant at Vanderbilt University Medical Center (VUMC) - Kidneys donated from deceased donors (either after brain death or after circulatory death), where the donor's legal decision-maker has agreed to donation and to the...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07394959 · Chinese PLA General Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2026
🇨🇳 CN

Who might be able to join this trial: - People aged 60 years or older - People who have unstable angina (a type of chest pain caused by reduced blood flow to the heart) and are scheduled to have a procedure called percutaneous coronary intervention (a procedure to open blocked or narrowed heart arteries) - People who h...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07403669 · Aventyn, Inc. Not Applicable · 2 countries Recruiting
Recruiting Not Applicable Est. completion 22 October 2026
🇸🇪 SE🇺🇸 US

Who might be able to join this trial: - Adults aged 18 or older of any gender may be considered for this trial. - People who have diabetes with a blood sugar control measure (A1C) of 7.5 or higher may be eligible. - People who have had a stent placed in their heart may be eligible. - People who have had open-heart bypa...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07405216 · Centenario Hospital Miguel Hidalgo Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 30 May 2027
🇲🇽 MX

Who might be able to join this trial: - People who are between 14 and 18 years old - People who currently live in Aguascalientes - People whose urine tests show a moderate amount of protein leaking into the urine (a specific measurement called ACR, falling between 30 and 300 mg/g) - People whose kidneys are filtering b...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT07413315 · Brugmann University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇧🇪 BE

Who might be able to join this trial: - People who have end-stage (terminal) kidney disease and are currently receiving hemodialysis (a machine that filters the blood) - People who have recently been admitted to hospital for a sudden or serious medical event Who may not be able to join: - People who have dementia or s...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07419828 · Shandong Suncadia Medicine Co., Ltd. Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 April 2030
🇨🇳 CN

Who might be able to join this trial: - People aged 18 to 79 years old at the time of signing the consent form, of any gender. - People whose kidneys are functioning at a reduced but not severely low level, and who also have a significant amount of protein in their urine — there are two combinations of kidney function...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07426380 · Eli Lilly and Company Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 1 October 2026
🇺🇸 US

**Who might be able to join this trial:** - People who weigh at least 55 kilograms and have a body mass index (BMI) between 19.0 and 40.0 - People who have no significant history of low blood sugar episodes that happened on their own or were caused by alcohol **For Group 1 only — additional criteria that may apply:**...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07437729 · Josip Juraj Strossmayer University of Osijek Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2029
🇭🇷 HR

Who might be able to join this trial: - People who have chronic kidney disease caused by high blood pressure, across a range of severity levels, who do not have diabetes and do not smoke - People who have high blood pressure (diagnosed according to 2023 international guidelines) but do not yet have kidney damage, and w...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07438002 · Casa di Cura Dott. Pederzoli Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
🇮🇹 IT

Who might be able to join this trial: - You must be willing and able to sign a consent form agreeing to take part in the trial - You have chronic kidney disease (CKD) at any stage (1 to 5) and are being treated without dialysis - You have been receiving regular kidney dialysis (hemodialysis) for at least 3 months - You...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07444203 · University of Pennsylvania Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 May 2027
🇺🇸 US

Who might be able to join this trial: - Adults aged 18 years or older - People whose kidneys are functioning at a level of at least 10 ml/min/1.73 m² (a measure of kidney function that the trial site can confirm from blood test results) - People who have already had a kidney biopsy, a kidney donor biopsy, or a kidney r...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07447375 · University of Salamanca Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇪🇸 ES

**Who might be able to join this trial:** - People who are currently enrolled in a chronic hemodialysis unit. - People who have been receiving hemodialysis treatment for more than 3 months. - People who are 40 years of age or older. - People whose hemoglobin (a measure of red blood cells) level is greater than 10 mg/dl...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07481526 · AstraZeneca Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2028
🇨🇳 CN

Who might be able to join this trial: - People aged 18 years or older, of any gender. - People who are willing and able to sign a written consent form to take part in the study. - People with a confirmed diagnosis of chronic kidney disease (CKD), shown by either reduced kidney function lasting at least 3 months, or sig...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07485075 · Steno Diabetes Center Copenhagen Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇩🇰 DK

**Who might be able to join this trial:** - People who have been diagnosed with Type 2 diabetes - People who are between 18 and 74 years old - People with a body mass index (a measure of body weight relative to height) below 35 - People whose kidneys are working at a reduced but specific level — with an eGFR (a kidney...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07487727 · Kind Pharmaceuticals LLC Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 December 2026
🇨🇳 CN

Who might be able to join this trial: - People who have been diagnosed with chronic kidney disease (CKD) at a moderate to severe stage (stage 3, 4, or 5), confirmed by a specific kidney function blood test at the start of the trial. - People who are not currently on dialysis and who show no signs of needing to start di...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07491042 · Oman Ministry of Health Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2026
Oman

**Who might be able to join this trial:** - You are 13 years old or older - You can be of any gender - You are currently on long-term peritoneal dialysis (a type of kidney treatment done through the abdomen) - Your kidneys still produce at least 150 ml of urine per day (roughly half a cup or more) **Who may not be abl...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07493642 · Fu Jen Catholic University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2026
🇹🇼 TW

Who might be able to join this trial: - Adults aged 20 or older who are awake and alert, can read, and are able to communicate in Mandarin or Taiwanese. - People who have been diagnosed with chronic kidney disease (a long-term condition affecting how the kidneys filter blood) at an early to moderate stage, confirmed by...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07494409 · Kind Pharmaceuticals LLC Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 30 October 2026
🇨🇳 CN

Who might be able to join this trial: - People who have been receiving stable dialysis (including haemodialysis, hemodiafiltration, hemofiltration, or peritoneal dialysis) for kidney failure for at least 16 weeks before joining, and whose doctor considers them to be following their dialysis treatment plan. - People who...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07498335 · Novartis Pharmaceuticals Phase 3 · 2 countries Recruiting
Recruiting Phase 3 Est. completion 15 September 2031
🇯🇵 JP🇺🇸 US

**Who might be able to join this trial:** - A parent or legal guardian must sign a consent form before any study-related assessments take place, and the child may also need to give their own agreement depending on their age and local rules. - Children and teenagers aged 2 to under 18 years old at the start of the tria...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07511283 · Odense University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2040
🇩🇰 DK

**Who might be able to join this trial:** *For people with chronic kidney disease (CKD) who may have or have been diagnosed with calciphylaxis (a serious condition affecting blood vessels and skin):* - People aged 18 or older - People who have chronic kidney disease (CKD) - People where there is a suspicion of, or a r...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07518719 · University of Pittsburgh Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2026
🇺🇸 US

Who might be able to join this trial: - Adults aged 18 or older who are patients at UPMC Clinic and have chronic kidney disease (CKD) that does not require dialysis, shown by a specific kidney function test result, along with at least one of the following: poorly controlled diabetes, high blood pressure over a 12-month...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07522944 · Alexandria University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 20 May 2026
🇪🇬 EG

**Who might be able to join this trial:** - Adults aged 18 years or older - People who have been diagnosed with end-stage kidney disease and have been receiving regular dialysis treatments for at least 3 months - People who are alert, aware of their surroundings, and able to communicate clearly - People who have been a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07535320 · University Hospital, Caen Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇫🇷 FR

Who might be able to join this trial: - Adults (18 years of age or older) - People with advanced chronic kidney disease who are receiving information about treatment options before surgery - People enrolled in a social security program - People who are able to read and understand French - People who are able to complet...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07547098 · First Affiliated Hospital of Fujian Medical University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 February 2031
🇨🇳 CN

**Who might be able to join this trial:** - People aged 18 years or older - People who have an inpatient hospital record at the First Affiliated Hospital of Fujian Medical University that can be used to link their data - People who have a heart or blood vessel condition, a kidney condition, a metabolic condition (such...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07554469 · Bayer Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 April 2029
🇪🇸 ES

**Who might be able to join this trial:** - People who have given their written agreement to take part in the study. - Men or women aged 18 years or older. - People who have chronic kidney disease linked to type 2 diabetes, along with higher-than-normal levels of a protein called albumin in their urine (a urine test re...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07555717 · Healionics Corporation Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
Paraguay

**Who might be able to join this trial:** - Adults aged 18 years or older - People who have given their written consent to take part in the trial - People who are willing and able to follow all trial procedures and attend all required visits for the full duration of the trial - People who are able to communicate effec...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07572890 · Adia Med of Winter Park LLC Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 1 January 2028
🇺🇸 US

Who might be able to join this trial: - People between 18 and 80 years of age - People who have a confirmed diagnosis of chronic kidney disease (CKD), with kidney function test results falling within a specific range (eGFR between 15 and 89 mL/min/1.73 m²) - People who are open to trying experimental treatments and are...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07591714 · Pardis Specialized Wellness Institute Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
Iran

**Who might be able to join this trial:** - Adults aged 18 or older who regularly receive hemodialysis at a dialysis centre - People who are medically stable enough to do a brief, seated activity during their dialysis session - People who are able to understand and follow instructions for eye exercises - People who are...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07592000 · University of Chicago Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 31 January 2030
🇺🇸 US

Who might be able to join this trial: - People aged 18 to 70 years old. - People who have had Type 1 diabetes for at least 5 years, with the condition first starting before age 40. - People who are able to understand and agree to take part in the study on their own behalf. - People who are able to follow all study proc...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07597005 · Universidade Federal Fluminense Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 November 2025
🇧🇷 BR

Who might be able to join this trial: - People who have been diagnosed with moderate to severe chronic kidney disease (stages 3 to 5) and are being managed without dialysis or transplant Who may not be able to join: - People who are currently pregnant - People who are currently breastfeeding - People who smoke - Peopl...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07607197 · Hospital Universitari Vall d'Hebron Research Institute Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 May 2027
🇪🇸 ES

Who might be able to join this trial: - Adults between 18 and 60 years of age. - People who have been diagnosed with end-stage kidney disease and are currently receiving regular dialysis. - People whose immune system has developed a very high level of antibodies that make it extremely difficult to find a compatible kid...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07613593 · Portsmouth Hospitals NHS Trust Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇬🇧 GB

**Who might be able to join this trial:** **For patients using the MyRenalCare digital platform (main study groups):** - People aged 18 or over who are receiving kidney care at the Wessex Kidney Centre and are registered with, or have been offered a place on, the MyRenalCare platform - People who are able to understan...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07614659 · Johan Sundström Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇸🇪 SE

Who might be able to join this trial: - People who live in the Uppsala region of Sweden - People who are turning 50, 55, 60, 65, 70, or 75 years old during the recruitment period - People who are able to give their informed consent to take part (meaning they can understand and agree to what the trial involves) Who may...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07619157 · Ono Pharmaceutical Co., Ltd. Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 30 November 2027
🇯🇵 JP

**Who might be able to join this trial:** *Healthy adult section:* - Japanese adult men - People aged 18 to 45 years at the time of signing consent - People with a body mass index (a measure of body weight relative to height) between 18.5 and under 25.0 at the screening visit *Chronic kidney disease patient section:*...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07619820 · CSL Behring Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 30 August 2027
🇨🇳 CN

Who might be able to join this trial: - People who have given written consent and are willing and able to follow all study requirements. - People aged 18 or older at the time of giving written consent. - People who have been diagnosed with end-stage kidney disease (kidney failure) and have been receiving regular dialys...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07626710 · Fondazione Policlinico Universitario Agostino Gemelli IRCCS Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 August 2028
🇮🇹 IT

**Who might be able to join this trial:** - People over 18 years old with a life expectancy of more than one year - People who have been recommended for a minimally invasive heart valve replacement procedure (called TAVI) by a specialist medical team - People who had at least one medical imaging scan using contrast dye...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07642778 · Cardenal Herrera University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇪🇸 ES

Who might be able to join this trial: - People who have been on haemodialysis (a kidney treatment that filters the blood using a machine) for at least 1 month, attending 3 sessions per week, each lasting 4 hours Who may not be able to join: - People who have had an amputation of one or both legs - People who have a co...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07656168 · China-Japan Friendship Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 April 2028
🇨🇳 CN

**Who might be able to join this trial:** - Adults aged over 18 years - People who have been on regular kidney dialysis (hemodialysis) for more than 3 months - People who receive hemodialysis three times per week, with each session lasting 4 hours - People whose dialysis is working at an adequate level, as measured by...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07666815 · Pedro Julian Flores Moreno Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 22 July 2026
🇲🇽 MX

**Who might be able to join this trial:** - People who receive their dialysis treatment at the State Haemodialysis Centre. - People who attend haemodialysis sessions three times per week. - People who are willing to sign a consent form agreeing to take part. - People who are 18 years of age or older, of any gender. - P...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07678073 · University of Gaziantep Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2026
Turkey (Türkiye)

**Who might be able to join this trial:** - Adults between 18 and 70 years of age who are in generally good to moderate overall health (as rated by a standard medical scale used by anaesthetists) - People scheduled for a planned kidney transplant where the kidney is coming from a living donor - People whose anaesthesia...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07690202 · University Hospital, Caen Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2027
🇫🇷 FR

**Who might be able to join this trial:** - Women aged 18 or older who are cisgender and have not yet gone through menopause - People who are being monitored at Caen University Hospital for chronic kidney disease (long-term kidney disease) - People who are not currently receiving any kidney replacement treatment, meani...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07694544 · EicOsis Human Health Inc. Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 31 December 2026
🇺🇸 US

**Who might be able to join this trial:** - People aged 55 or older, of any gender - People who are willing and able to sign a written consent form to take part in the study - People with chronic kidney disease (CKD) at a moderate-to-severe stage (stage 3b–5), who are not currently on dialysis — or, for the comparison...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07694791 · Hospital Universitario Dr. Jose E. Gonzalez Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
🇲🇽 MX

Who might be able to join this trial: - People who are 18 years of age or older. - People who have been diagnosed with kidney disease and have been doing peritoneal dialysis at home for at least 1 month. Who may not be able to join: - People who are unable to eat or receive nutrition through a feeding tube. - People w...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07705269 · Universidad Autonoma de Nuevo Leon Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
🇲🇽 MX

Who might be able to join this trial: - Adults aged 18 or older who have end-stage kidney failure and have been receiving hemodialysis (a machine-based kidney treatment) for at least 3 months - People who have been admitted to hospital and need a medical procedure to remove excess fluid from the body for the first time...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Advocacy and support in Australia

Organisations that can offer information, support, or connection for Chronic Kidney Disease. Where more than one is listed, they serve different needs or regions, so choose whichever fits your situation.

Kidney Health Australia is the national body for people affected by kidney disease.

This is a starting point, not medical advice or an endorsement. Contact details change; search the organisation name to find its current website.